UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

_____________________________

FORM 20-F



_____________________________



| ̈ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ----------------------------------------------------------------------------------------------



OR



| ̈ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|- | ------------------------------------------------------------------------------------



For the fiscal year ended ______________



|OR ̈ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- | ----------------------------------------------------------------------------------------



|ORx | SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|--- | -------------------------------------------------------------------------------------------



Date of event requiring this
shell company report: December 28, 2012



Commission file number:
000-54022



EASY HEALTH TECHNOLOGIES LTD.
(Exact name of Registrant as Specified in its Charter)



British Virgin Islands
(Jurisdiction of Incorporation or Organization)



No. 16, 219th Street, Tiedong
District

Anshan, Liaoning Province 200120

People’s Republic of China
(Address of principal executive offices)

Wei Dong

No. 16, 219th Street, Tiedong
District

Anshan, Liaoning Province 200120

People’s Republic of China
86-412-223-8188

easyhealth2012@163.com

(Name, Telephone, E-mail and/or Facsimile
Number and Address of Company Contact Person)



Securities registered or to be registered
pursuant to Section 12(b) of the Act:



|Title of Each Class | Name of Each Exchange On Which Registered
|------------------- | -----------------------------------------
|None                | None                                     



Securities registered or to be registered
pursuant to Section 12(g) of the Act:



Ordinary Shares, par value $.01 per share
(Title of Class)



Securities for which there is a reporting
obligation pursuant to Section 15(d) of the Act:



None
(Title of Class)



The number of outstanding shares of each of
the issuer’s classes of capital or common stock as of December 28, 2012 was 20,000,000
ordinary shares par value $0.01 per share.



Indicate by check mark if the registrant is
a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.



Yes
 ̈ No x



If
this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934.



Yes
 ̈ No  ̈



Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),
and (2) has been subject to such filing requirements for the past 90 days:



Yes
x No  ̈



Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).



Yes
x No  ̈



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition
of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):



Large
accelerated filer  ̈       Accelerated filer  ̈    Non-accelerated filer x



Indicate
by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:



xU.S. GAAP  ̈ International Financial Reporting Standards as issued by the
International Accounting
Standards Board  ̈ Other  ̈



If
“Other” has been checked in response to the previous question, indicate by check mark which financial statement item
the registrant has elected to follow: Item 17  ̈ Item 18  ̈



If
this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange
Act). Yes  ̈ No  ̈











EASY HEALTH TECHNOLOGIES LTD.
(formerly Glorious Pioneer Investments, Ltd.)
FORM 20-F SHELL COMPANY REPORT

TABLE OF CONTENTS



|          |                                                                              | Page
|--------- | ---------------------------------------------------------------------------- | ----
|          |                                                                              |     
|PART I    |                                                                              |     
|Item 1.   | Identity of Directors, Senior Management and Advisors                        | 2   
|Item 2.   | Offer Statistics and Expected Timetable                                      | 2   
|Item 3.   | Key Information                                                              | 2   
|Item 4.   | Information on the Company                                                   | 11  
|Item 4A.  | Unresolved Staff Comments                                                    | 19  
|Item 5.   | Operating and Financial Review and Prospects                                 | 20  
|Item 6.   | Directors, Senior Management, and Employees                                  | 22  
|Item 7.   | Major Shareholders and Related Party Transactions                            | 25  
|Item 8.   | Financial Information                                                        | 26  
|Item 9.   | The Offer and Listing                                                        | 26  
|Item 10.  | Additional Information                                                       | 27  
|Item 11.  | Quantitative and Qualitative Disclosures About Market Risk                   | 33  
|Item 12.  | Description of Securities Other Than Equity Securities                       | 33  
|          |                                                                              |     
|PART II   |                                                                              |     
|Item 13.  | Defaults, Dividend Arrearages and Delinquencies                              | 33  
|Item 14.  | Material Modifications to the Rights of Security Holders and Use of Proceeds | 33  
|Item 15.  | Controls and Procedures                                                      | 33  
|Item 16.  | Reserved                                                                     | 33  
|Item 16A. | Audit Committee Financial Expert                                             | 33  
|Item 16B. | Code of Ethics                                                               | 33  
|Item 16C. | Principal Accountiing Fees and Services                                      | 33  
|Item 16D. | Exemptions from the Listing Standards for Audit Committees                   | 33  
|Item 16E. | Purchases of Equity Securities by the Issuer and Affiliated Purchasers       | 34  
|Item 16F. | Change in Registrant's Certifying Accountant                                 | 34  
|Item 16G. | Corporate Governance                                                         | 34  
|tem 16G.  | Corporate Governance                                                         | 34  
|          |                                                                              |     
|PART III  |                                                                              |     
|Item 17.  | Financial Statements                                                         | 34  
|Item 18.  | Financial Statements                                                         | 35  
|Item 19.  | Exhibits                                                                     | 35  











CERTAIN INFORMATION



In this shell company
report on Form 20-F, unless otherwise indicated, “we,” “us,” “our,” the “Company”
and “Easy Health” refer to Easy Health Technologies Ltd., formerly known as Glorious Pioneer Investments Ltd., a company
organized in the British Virgin Islands, and its subsidiaries, subsequent to the reverse acquisition referred to below. The “reverse
acquisition” refers to the share exchange between Easy Health and its sole shareholder and the shareholders of Oriental Honour
International Group Limited, a Hong Kong company (“Oriental Honour”), which resulted in the acquisition of all of the
outstanding securities of Oriental Honour by Easy Health, which was consummated on December 28, 2012.



Unless the context indicates
otherwise, all references to “China” or “PRC” refer to the People’s Republic of China. All references
to “Renminbi” or “RMB” are to the legal currency of the PRC, and all references to “U.S. dollars,”
“dollars” and “$” are to the legal currency of the United States. This report contains translations of
Renminbi amounts into U.S. dollars at specified rates solely for the convenience of the reader. We make no representation that
the Renminbi or U.S. dollar amounts referred to in this report could have been or could be converted into U.S. dollars or Renminbi,
as the case may be, at any particular rate or at all. On July 31, 2012, the cash buying rate announced by the People’s Bank
of China was RMB 6.33 to $1.00. On January 4, 2013, the cash buying rate announced by the People’s Bank of China was RMB
6.23 to $1.00.



FORWARD-LOOKING STATEMENTS



This report contains “forward-looking
statements” that represent our beliefs, projections and predictions about future events. All statements other than statements
of historical fact are “forward-looking statements” including any projections of earnings, revenue or other financial
items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed
new projects or other developments, any statements regarding future economic conditions or performance, any statements of management’s
beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words
such as “may”, “will”, “should”, “could”, “would”, “predicts”,
“potential”, “continue”, “expects”, “anticipates”, “future”, “intends”,
“plans”, “believes”, “estimates” and similar expressions, as well as statements in the future
tense, identify forward-looking statements.



These statements are necessarily
subjective and involve known and unknown risks, uncertainties and other important factors that could cause our actual results,
performance or achievements, or industry results, to differ materially from any future results, performance or achievements described
in or implied by such statements. Actual results may differ materially from expected results described in our forward-looking statements,
including with respect to correct measurement and identification of factors affecting our business or the extent of their likely
impact, and the accuracy and completeness of the publicly available information with respect to the factors upon which our business
strategy is based or the success of our business.



Forward-looking statements
should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of whether,
or the times by which, our performance or results may be achieved. Forward-looking statements are based on information available
at the time those statements are made and management’s belief as of that time with respect to future events, and are subject
to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested
by the forward-looking statements. Important factors that could cause such differences include, but are not limited to, those factors
discussed under the headings “Risk Factors”, “Operating and Financial Review and Prospects” and elsewhere
in this report.





1







PART
I



|ITEM 1. | Identity of Directors, Senior Management and Advisors
|------- | -----------------------------------------------------



1.A. Directors and Senior Management



The following table lists
the members of the Company’s board of directors:



|Name     |  | Age |  | Position(s)          
|-------- |  | --- |  | ---------------------
|Wei Dong |  | 48  |  | Chairman of the Board
|Song Gu  |  | 30  |  | Director             



The business address for
each of our directors is:c/o Anshan Easy Health Technology Development Co,. Ltd., 16 219 Street,
Anshan City, Liaoning, 114002, People’s Republic of China.



The following table lists
the senior management of the Company:



|Name     |  | Age |  | Position(s)          
|-------- |  | --- |  | ---------------------
|Wei Dong |  | 48  |  | Chairman of the Board
|Song Gu  |  | 30  |  | Vice General Manager 



The business address for
each of the members of senior management is:c/o Anshan Easy Health Technology Development
Co,. Ltd., 16 219 Street, Anshan City, Liaoning, 114002, People’s Republic of China.



See Item 6.A. –
Directors and Senior Management below for more information about our directors and executive officers.



1.B. Advisors



The Company’s legal
advisor in the United States is Robert Brantl, Esq., 52 Mulligan Lane, Irvington, NY 10533-1106.



1.C. Auditors



The Company’s auditors are: Goldman
Kurland and Mohidin, LLP, 16133 Ventura Blvd., Suite 880, Encino, CA 91436. See Item 16.F – Change in Registrant’s
Certifying Accountant below for information about the change in our auditor following the reverse acquisition.



Goldman Kurland and Mohidin,
LLP has confirmed it is independent with respect to the Company under the guidelines of the SEC and the Independence Standards
Board.



|ITEM 2. | Offer Statistics and Expected Timetable
|------- | ---------------------------------------



Not Applicable.



|ITEM 3. | KEY INFORMATION
|------- | ---------------



3.A. Selected Financial Data



The following selected
financial information should be read in connection with, and is qualified by reference to, our consolidated financial statements
and their related notes and the section entitled “Operating and Financial Review and Prospects,” each of which is included
elsewhere in this report. The consolidated statements of operations and comprehensive income data for the period from August 1,
2011 (inception) to July 31, 2012 and the balance sheet data as of July 31, 2012 are derived from the audited consolidated financial
statements of Oriental Honour International Group Limited included elsewhere in this report. Our historical results for any of
these periods are not necessarily indicative of results to be expected in any future period.



2







Statement of Operations
and Comprehensive Loss:



|                       |  | Period from August 1, 2011
    (Inception) through July 31, 2012 |       
|---------------------- |  | ---------------------------------------------------------------- | ------
|Revenue                |  | $                                                                | 0     
|Operating Expenses     |  |                                                                  | 7,817 
|Loss from Operations   |  |                                                                  | (7,817
|Net Loss               |  |                                                                  | (7,925
|Net Comprehensive Loss |  |                                                                  | (8,233



Balance Sheet:



|                           |  | As at July 31, 2012 |          
|-------------------------- |  | ------------------- | ---------
|Cash                       |  | $                   | 1,701,659
|Total Current Assets       |  |                     | 1,848,121
|Total Assets               |  |                     | 1,854,508
|Total Liabilities          |  |                     | 291,566  
|Total Shareholders’ Equity |  |                     | 1,562,942



Dividends Declared:



The Company has never
declared a dividend payable to shareholders.



3.A.3. Exchange Rates



Not Applicable.



3.B. Capitalization and Indebtedness



The following table sets
forth our capitalization and indebtedness as of July 31, 2012. This information should be read in conjunction with our consolidated
financial statements and the notes relating to such statements appearing elsewhere in this report.



|                           |  | As at July 31, 2012 |          
|-------------------------- |  | ------------------- | ---------
|Indebtedness               |  | $                   | 98,698   
|Total Shareholders’ Equity |  |                     | 1,562,942



3.C. Reasons for the Offer and Use of Proceeds



Not Applicable.



3







3.D. Risk Factors



You should carefully
consider the risks described below in evaluating our business before investing in our ordinary shares. If any of the following
risks were to occur, our business, results of operations and financial condition could be harmed. In that case, the trading price
of our ordinary shares could decline and you might lose all or part of your investment in our ordinary shares. You should also
refer to the other information set forth in this report, including our consolidated financial statements and the related notes
and the section captioned “Operating and Financial Review and Prospects” before deciding whether to invest in our ordinary
shares.



Risks Related to Our Business



Our business and operations are newly
established. Unless we manage our growth effectively, our business will fail.



Anshan Easy Health was incorporated in March
2012.  The two members of our management had prior experience in the health care industry. But the extrapolation of that
experience into a marketing business on the magnitude contemplated by Anshan Easy Health will place significant demands on our
management, and on our operational and financial infrastructure. If we do not effectively manage our operations, the quality of
our marketing program will suffer, which would negatively affect our operating results. The complexity of this undertaking means
that we are likely to face many challenges, some of which are not yet foreseeable. Problems may occur with our technology development,
our development of a marketing network, and with our ability to sell our services to our customers. If we are not able to overcome
these obstacles and operate efficiently, our business plan may fall short of its goals, and our ability to manage our growth could
be hurt.



Our ability to maintain
or increase our revenue could be harmed if we are unable to sign more Regional Agent Agreements.



Our business plan contemplates
that we will engage regional sales agents as the sole conduit for distribution of our services. To date, we have engaged five regional
agents, whose exclusive regions represent only a very small portion of China. The success of our business plan requires that we
find a large number of other entities that are willing to devote a large portion of their business attention to the distribution
of our diagnostic services and whose personnel have the skill and experience necessary to be successful in effecting that distribution.
If we are unable to engage a sufficient number of such agents, our business plan will fail.



We may have difficulty defending our
intellectual property rights from infringement, which may undermine our competitive position.



Our ability to compete effectively with
the hospital industry and other entities providing medical diagnostic services will depend on our ability to distinguish our services
from those of our competitors.  The primary distinction on which we intend to rely will be the quality of our diagnoses,
particularly relative to the cost. To preserve that claim, it is essential that we preserve the confidentiality of our software
design and database. We will rely on trade secret laws and restrictions on disclosure to protect our intellectual property rights.
Unauthorized use of our database could damage our ability to compete effectively.



If litigation becomes necessary to enforce
our intellectual property rights, protect our trade secrets or determine the validity and scope of the proprietary rights of others,
such litigation may be costly and may divert management attention away from our business. An adverse determination in any such
litigation would impair our intellectual property rights and could harm our business, prospects and reputation. Enforcement of
judgments in China is uncertain and even if we are successful in litigation it may not provide us with an effective remedy. In
addition, we have no insurance coverage against litigation costs and would have to bear all costs arising from such litigation
to the extent we are unable to recover them from other parties. The occurrence of any of the foregoing could have a material adverse
effect on our business, financial condition and results of operations.



Competition in the
health service industry could cause us to lose market share, thereby materially and adversely affecting our business, results of
operations and financial condition.



To develop a market for
our diagnostic services, we will have to persuade potential clients to prefer our diagnostic services over those offered by more
traditional health care providers, such as hospitals. Since we have only this year initiated our marketing operations, we do not
have adequate experience to determine whether we will be successful in competing with the medical industry.



4







In addition, our success,
if it occurs, is likely to draw other diagnostic services into the market. Because our technology does not involve any patent and
because the cost of our equipment is low, there are relatively low barriers to entry into the medical diagnostic field. A well-financed
effort by a competitor to capture market share could have a seriously adverse affect on our business, results of operations and
financial condition.



Our success depends in large
part upon our senior management and key personnel and our inability to attract or retain these individuals could materially and
adversely affect our business, results of operations and financial condition.



We are highly dependent
on our senior management, including our Chairman of the Board, Wei Dong and our Vice General Manager, Song Gu. Our future performance
will be dependent upon the continued service of members of our senior management. Competition for senior management in our industry
is intense, and we may not be able to retain our senior management and key personnel or attract and retain new senior management
and key personnel in the future, which could materially and adversely affect our business, results of operations and financial
condition.



Product liability claims could materially
impact operating results and profitability.



Like any medical diagnostic device, our
diagnostic equipment is not completely accurate. Our diagnoses include some false positives and, more significantly, can at times
fail to detect and identify a disease or other medical condition. The result of our failure to provide a client an accurate diagnosis
could be that the patient incurs unnecessary medical expenses. But it could also be that the patient suffers from a disease or
other condition that could have been avoided had the diagnosis been accurate. If a client suffers such a result, she or he may
initiate legal action against us.  Existing laws and regulations in China do not require us to maintain third party liability
insurance to cover product liability claims.  However, if a product liability claim is brought against us, it may, regardless
of merit or eventual outcome, result in damage to our reputation, breach of contract with our customers, decreased demand for our
services, costly litigation, loss of revenue, and our inability to expand our operations to a profitable level.



The staff of our accounting department
lack training and experience in U.S. Generally Accepted Accounting Principles “U.S. GAAP”), which may result in accounting
errors in the financial statements that we file with the Securities and Exchange Commission.



Our executive offices are located in Anshan
in the PRC. Our entire bookkeeping and accounting staff is located there. Our books and records are maintained in Chinese, using
Chinese accounting principles. Chinese accounting principles vary in many important respects from U.S. accounting principles. To
file our Company’s financial statements with the Securities and Exchange Commission, our accounting staff must convert the
financial statements from Chinese GAAP to U.S. GAAP. However, none of the members of our accounting staff has extensive experience
or training in the preparation of financial statements under U.S. GAAP. Neither do we have any employee who has previous experience
in accounting for a U.S. public company. This situation creates a risk that the financial statements we file with the SEC will
fail to present our financial condition and/or results of operations as required by SEC rules and the principles of accounting
generally applied in the United States.



We will incur increased costs
as a result of being a public company.



As a public company, we
will incur significant legal, accounting and other expenses that we did not incur as a private company. We expect the rules and
regulations to which public companies are subject, including Sarbanes-Oxley, to increase our legal, accounting and financial compliance
costs and to make certain corporate activities more time-consuming and costly. In addition, we will incur additional costs associated
with our public company reporting requirements.



5







Risks Related to the VIE Agreements



The PRC government
may determine that our corporate structure is not in compliance with applicable PRC laws, rules and regulations.



Our wholly owned subsidiary,
Jinwo Shanghai, manages and operates our business through Anshan Easy Health, a PRC company owned by Ms. Lingxiang Zhang and Mr.
Song Gu. Jinwo Shanghai operates Anshan Easy Health’ business pursuant to contractual arrangements with Anshan Easy Health
and Ms. Zhang and Mr.Gu, which arrangements we refer to throughout this report as the VIE Agreements. Almost all economic benefits
and risks arising from Anshan Easy Health’ operations have been transferred to Jinwo Shanghai under these agreements. Details
of the VIE Agreements are set out below in Item 4A – “History and Development of the Company – Our Subsidiaries
- VIE Agreements.”



There are risks involved
in the operation of our business in reliance on the VIE Agreements, including the risk that the VIE Agreements may be determined
by PRC regulators or courts to be unenforceable. If the VIE Agreements were determined to be in breach of any existing or future
PRC laws or regulations, the relevant regulatory authorities would have broad discretion in dealing with such breach, including:



| | · | imposing economic penalties;
| | - | ----------------------------



| | · | discontinuing or restricting the operations of Jinwo Shanghai or Anshan Easy Health;
| | - | ------------------------------------------------------------------------------------



| | · | imposing conditions or requirements in respect of the VIE Agreements with which Jinwo Shanghai may
not be able to comply;
| | - | -------------------------------------------------------------------------------------------------------------------------



| | · | requiring our company to restructure the relevant ownership structure or operations;
| | - | ------------------------------------------------------------------------------------



| | · | taking other regulatory or enforcement actions that could adversely affect our company’s business;
and
| | - | ------------------------------------------------------------------------------------------------------



| | · | revoking the business licenses and/or the licenses or certificates of Jinwo Shanghai or Anshan Easy
Health, and voiding the VIE Agreements.
| | - | -------------------------------------------------------------------------------------------------------------------------------------------



Any of these actions could
adversely affect our ability to manage, operate and gain the financial benefits of Anshan Easy Health, which would have a material
adverse impact on our business, financial condition and results of operations.



If we were unable to enforce the terms
of the entrusted management agreements between Jinwo Shanghai and Anshan Easy Health, we would have no business operations.



All of our business activities are carried
out by Anshan Easy Health. Substantially all of the assets shown on our balance sheet are owned by Anshan Easy Health. However,
Easy Health Technologies Ltd., the public company owned by our shareholders, does not own any equity in Anshan Easy Health. Instead,
we consolidate the assets and results of operations of Anshan Easy Health with the financial statements of Easy Health Technologies
Ltd. by reason of a set of five contracts. Those contracts transfer 100% of the benefits of and responsibilities for the operations
of Anshan Easy Health to a wholly-owned subsidiary of Easy Health Technologies. As a result, under U.S. GAAP, Anshan Easy Health
is deemed to be a variable interest entity with respect to that subsidiary, and so is a consolidated entity within the Company.
Our entitlement to those benefits, however, depends on our ability to enforce the agreements between our subsidiary, Jinwo Shanghai,
and Anshan Easy Health. If a dispute arose between those entities that could not be resolved amicably, we would have to resort
to a court or arbitration tribunal in the PRC to secure our rights with respect to Anshan Easy Health. We are not aware, however,
of a body of reported decisions regarding the enforceability of agreements of this sort under the laws of the PRC. It is possible,
therefore, that the Chinese tribunal would decide that the agreements were not enforceable, either as a matter of national policy
or for some other reason. If that were to occur, Easy Health Technologies Ltd. would have no business operations or assets, and
its outstanding common stock would be essentially worthless.



6







The shareholders of Anshan Easy
Health may breach, or cause Anshan Easy Health to breach, the VIE Agreements.



Lingxiang Zhang, the primary shareholder
of Anshan Easy Health, may breach, or cause Anshan Easy Health to breach, the VIE Agreements because her equity interests in Anshan
Easy Health is much greater than her equity interests in our company. As a result, Ms. Zhang may breach a contract with us if she
believes that such breach will lead to greater economic benefit for her. If the shareholders of Anshan Easy Health were to breach,
or cause Anshan Easy Health to breach, the VIE Agreements for this reason or any other reason, we may have to rely on legal or
arbitral proceedings to enforce our contractual rights, including specific performance, injunctive relief or claiming damages.
Such arbitral and legal proceedings may cost us substantial financial and other resources, and result in disruption of our business,
and we cannot assure you that the outcome will be in our favor.



The payment arrangement
under the VIE Agreements may be challenged by the PRC tax authorities.



We generate our revenues
through payments that we receive from Anshan Easy Health pursuant to the VIE Agreements. We could face adverse tax consequences
if the PRC tax authorities determine that the VIE Agreements were not entered into based on arm’s length negotiations. For
example, PRC tax authorities may adjust our income and expenses for PRC tax purposes which could result in our being subject to
higher tax liability.



Risks Related to Doing Business in
China



Changes in China’s political
or economic situation could harm us and our operating results.



Economic reforms adopted by the Chinese
government have had a positive effect on the economic development of the country, but the government could change these economic
reforms or any of the legal systems at any time. This could either benefit or damage our operations and profitability. Some of
the things that could have a negative effect are:



| | · | level of government involvement in the economy;
| | - | -----------------------------------------------

| | · | control of foreign exchange;
| | - | ----------------------------

| | · | methods of allocating resources;
| | - | --------------------------------

| | · | balance of payments position;
| | - | -----------------------------

| | · | international trade restrictions; and
| | - | -------------------------------------

| | · | international conflict.
| | - | -----------------------



The Chinese economy differs from the economies
of most countries in Europe and the Americas in a number of ways. For example, state-owned enterprises still constitute a large
portion of the Chinese economy, and weak corporate governance and the lack of a flexible currency exchange policy still prevail
in China. As a result of these differences, we may not develop in the same way or at the same rate as might be expected if the
Chinese economy was similar to those of European or American countries.



Increased government regulation of
our marketing operations could diminish our profits.



At present, there is no significant government
regulation of the business of providing electromagnetic medical diagnosis.  Other developed countries, in particular
members of the European Community, have far more extensive regulation of the commercial use of medical devices, including strict
limitations on the health-related claims that can be made without scientifically-tested evidence.  It is not unlikely,
therefore, that China will increase its regulation of our activities in the future.  To the extent that new regulations
required us to conduct scientific tests of the efficacy of our TDS device, the expense of such testing would reduce our profitability.  In
addition, to the extent that the accuracy of the TDS in diagnosis could not be fully supported by scientific evidence, our sales
might be reduced.



7







Most of our revenues are denominated
in Renminbi, which is not freely convertible for capital account transactions and may be subject to exchange rate volatility.



We are exposed to the
risks associated with foreign exchange controls and restrictions in China, as our revenues are primarily denominated in Renminbi,
which is currently not freely exchangeable. The PRC government imposes control over the convertibility between Renminbi and foreign
currencies. Under the PRC foreign exchange regulations, payments for “current account” transactions, including remittance
of foreign currencies for payment of dividends, profit distributions, interest and operation-related expenditures, may be made
without prior approval but are subject to procedural requirements. Strict foreign exchange control continues to apply to “capital
account” transactions, such as direct foreign investment and foreign currency loans. These capital account transactions must
be approved by, or registered with, the PRC State Administration of Foreign Exchange, or SAFE. Further, capital contribution by
an offshore shareholder to its PRC subsidiaries may require approval by the Ministry of Commerce in China or its local counterparts.
We cannot assure you that we will be able to meet all of our foreign currency obligations to remit profits out of China or to fund
operations in China.



On August 29, 2008, SAFE
promulgated the Circular on the Relevant Operating Issues concerning the Improvement of the Administration of Payment and Settlement
of Foreign Currency Capital of Foreign-Invested Enterprises, or Circular 142, to regulate the conversion by foreign invested enterprises,
or FIEs, of foreign currency into Renminbi by restricting how the converted Renminbi may be used. Circular 142 requires that Renminbi
converted from the foreign currency-dominated capital of a FIE may be used only for purposes within the business scope approved
by the applicable government authority and may not be used for equity investments within the PRC unless specifically provided.
In addition, SAFE strengthened its oversight over the flow and use of Renminbi funds converted from the foreign currency-dominated
capital of a FIE. The use of such Renminbi may not be changed without approval from SAFE, and may not be used to repay Renminbi
loans if the proceeds of such loans have not yet been used. Compliance with Circular 142 may delay or inhibit our ability to complete
such transactions, which could affect our ability to expand our business.



Fluctuation in the value of
the Renminbi and of the U.S. dollar may have a material adverse effect on investments in our ordinary shares.



Any significant revaluation
of the Renminbi may have a material adverse effect on the U.S. dollar equivalent amount of our revenues and financial condition
as well as on the value of, and any dividends payable on, our ordinary shares in foreign currency terms. For instance, a decrease
in the value of Renminbi against the U.S. dollar could reduce the U.S. dollar equivalent amounts of our financial results, the
value of your investment in our ordinary shares and the dividends we may pay in the future, if any, all of which may have a material
adverse effect on the prices of our common shares. All of our revenues are denominated in Renminbi. Any further appreciation of
the Renminbi against the U.S. dollar may result in significant exchange losses.



Prior to 1994, the Renminbi
experienced a significant net devaluation against most major currencies, and there was significant volatility in the exchange rate
during certain periods. Upon the execution of the unitary managed floating rate system in 1994, the Renminbi was devalued by 50%
against the U.S. dollar. Since 1994, the Renminbi to U.S. dollar exchange rate has largely stabilized. On July 21, 2005, the People’s
Bank of China announced that the exchange rate of U.S. dollar to Renminbi would be adjusted from $1 to RMB8.27 to $1 to RMB8.11,
and it ceased to peg the Renminbi to the U.S. dollar. Instead, the Renminbi would be pegged to a basket of currencies, whose components
would be adjusted based on changes in market supply and demand under a set of systematic principles. On September 23, 2005, the
PRC government widened the daily trading band for Renminbi against non-U.S. dollar currencies from 1.5% to 3.0% to improve the
flexibility of the new foreign exchange system. Since the adoption of these measures, the value of Renminbi against the U.S. dollar
has fluctuated on a daily basis within narrow ranges, but overall has further strengthened against the U.S. dollar. In June 2010,
the Chinese government announced its intention to allow the Renminbi to fluctuate within the June 2005 parameters. There remains
international pressure on the PRC government to further liberalize its currency policy, which could result in a further and more
significant appreciation in the value of the Renminbi against the U.S. dollar. The Renminbi may be revalued further against the
U.S. dollar or other currencies, or may be permitted to enter into a full or limited free float, which may result in an appreciation
or depreciation in the value of the Renminbi against the U.S. dollar or other currencies.



8







Under the New Enterprise Income Tax
Law, we may be classified as a “resident enterprise” of China. Such classification would likely result in unfavorable
tax consequences to us and our non-PRC shareholders.



China passed a New Enterprise Income Tax
Law, or the New EIT Law, which became effective on January 1, 2008. Under the New EIT Law, an enterprise established outside of
China with de facto management bodies within China is considered a resident enterprise, meaning that it can be treated in a manner
similar to a Chinese enterprise for enterprise income tax purposes. The implementing rules of the New EIT Law define de facto management
as “substantial and overall management and control over the production and operations, personnel, accounting, and properties”
of the enterprise. In addition, a circular issued by the State Administration of Taxation on April 22, 2009 clarified that dividends
and other income paid by such resident enterprises will be considered to be PRC source income, subject to PRC withholding tax,
currently at a rate of 10%, when recognized by non-PRC enterprise shareholders. This recent circular also subjects such resident
enterprises to various reporting requirements with the PRC tax authorities.



Although all of our management is currently
located in the PRC, it remains unclear whether the PRC tax authorities would require or permit our overseas registered entities
to be treated as PRC resident enterprises. If the PRC tax authorities determine that we are a resident enterprise for PRC enterprise
income tax purposes, a number of unfavorable PRC tax consequences could follow. First, we may be subject to the enterprise income
tax at a rate of 25% on our worldwide taxable income as well as PRC enterprise income tax reporting obligations. In our case, this
would mean that income such as interest on offering proceeds and non-China source income would be subject to PRC enterprise income
tax at a rate of 25%. Second, although under the New EIT Law and its implementing rules dividends paid to us from our PRC subsidiaries
would qualify as tax-exempt income, we cannot guarantee that such dividends will not be subject to a 10% withholding tax, as the
PRC foreign exchange control authorities, which enforce the withholding tax, have not yet issued guidance with respect to the processing
of outbound remittances to entities that are treated as resident enterprises for PRC enterprise income tax purposes. Finally, it
is possible that future guidance issued with respect to the new resident enterprise classification could result in a situation
in which a 10% withholding tax is imposed on dividends we pay to our non-PRC shareholders and with respect to gains derived by
our non-PRC shareholders from transferring our shares.



Restrictions under PRC law on Jinwo
Shanghai’s ability to pay dividends and make other distributions could materially and adversely affect our ability to grow,
make investments or acquisitions that could benefit our business, pay dividends to you, and otherwise fund and conduct our business.



PRC regulations restrict
the ability of PRC subsidiaries to pay dividends and make other payments to their offshore parent company. PRC legal restrictions
permit payments of dividends by PRC subsidiaries only out of their accumulated after-tax profits, if any, determined in accordance
with PRC accounting standards and regulations. PRC subsidiaries are also required under PRC laws and regulations to allocate at
least 10% of their annual after-tax profits determined in accordance with PRC GAAP to a statutory general reserve fund until the
amounts in said fund reaches 50% of their registered capital. Allocations to these statutory reserve funds can be used only for
specific purposes and are not transferable to us in the form of loans, advances, or cash dividends. Any limitations on the ability
of Jinwo Shanghai to transfer funds to us could materially and adversely limit our ability to grow, make investments or acquisitions
that could be beneficial to our business, pay dividends and otherwise fund and conduct our business.



If the China Securities Regulatory
Commission, or CSRC, or another Chinese regulatory agency, determines that CSRC approval is required in connection with our reverse
acquisition or our contractual arrangement with Jinwo Shanghai and its shareholders, we may become subject to penalties.



On August 8, 2006, six Chinese regulatory
agencies, including the Chinese Securities Regulatory Commission, or CSRC, promulgated the M&A Regulation, which became effective
on September 8, 2006 and was subsequently revised on June 22, 2009. This regulation, among other things, has provisions that require
offshore special purpose vehicles formed for the purpose of acquiring Chinese domestic companies and directly or indirectly established
or controlled by Chinese entities or individuals, to obtain the approval of the CSRC prior to publicly listing their securities
on an overseas stock market. On September 21, 2006, the CSRC published on its official website a notice specifying the documents
and materials that are required to be submitted for obtaining CSRC approval. It is not clear how the provisions in the regulation
regarding the offshore listing and trading of the securities of a special purpose vehicle apply to us. We believe, based on the
interpretation of the regulation and the practice experience of our Chinese legal counsel that CSRC approval is not required for
the reverse acquisition between Oriental Honour and Jinwo Shanghai or our contractual arrangement with Jinwo Shanghai and its shareholders.
There remains some uncertainty as to how this regulation will be interpreted or implemented. If the CSRC or another Chinese regulatory
agency subsequently determines that the CSRC’s approval is required for this reverse acquisition or our contractual arrangement
with Jinwo Shanghai and its shareholders, we may face sanctions by the CSRC or another Chinese regulatory agency. If this happens,
these regulatory agencies may impose fines and penalties on our operations in China, limit our operating privileges in China, restrict
or prohibit payment or remittance of dividends to us or take other actions that could have a material adverse effect on our business,
financial condition, results of operations, reputation and prospects.



9







Failure to comply with PRC regulations
relating to the establishment of offshore special purpose companies by PRC residents may subject our PRC resident shareholders
to personal liability, limit our ability to acquire PRC companies or to inject capital into our PRC subsidiary or affiliate, limit
our PRC subsidiary’s and affiliate’s ability to distribute profits to us or otherwise materially adversely affect us.



In October 2005, SAFE issued the Notice
on Relevant Issues in the Foreign Exchange Control over Financing and Return Investment Through Special Purpose Companies by Residents
Inside China, generally referred to as Circular 75, which required PRC residents to register with the competent local SAFE branch
before establishing or acquiring control over an offshore special purpose company, or SPV, for the purpose of engaging in an equity
financing outside of China on the strength of domestic PRC assets originally held by those residents. Internal implementing guidelines
issued by SAFE, which became public in June 2007 (known as Notice 106), expanded the reach of Circular 75 by (1) purporting to
cover the establishment or acquisition of control by PRC residents of offshore entities which merely acquire “control”
over domestic companies or assets, even in the absence of legal ownership; (2) adding requirements relating to the source of the
PRC resident’s funds used to establish or acquire the offshore entity; covering the use of existing offshore entities for
offshore financings; (3) purporting to cover situations in which an offshore SPV establishes a new subsidiary in China or acquires
an unrelated company or unrelated assets in China; and (4) making the domestic affiliate of the SPV responsible for the accuracy
of certain documents which must be filed in connection with any such registration, notably, the business plan which describes the
overseas financing and the use of proceeds. Amendments to registrations made under Circular 75 are required in connection with
any increase or decrease of capital, transfer of shares, mergers and acquisitions, equity investment or creation of any security
interest in any assets located in China to guarantee offshore obligations, and Notice 106 makes the offshore SPV jointly responsible
for these filings. Failure to comply with the requirements of Circular 75, as applied by SAFE in accordance with Notice 106, may
result in fines and other penalties under PRC laws for evasion of applicable foreign exchange restrictions. Any such failure could
also result in the SPV’s affiliates being impeded or prevented from distributing their profits and the proceeds from any
reduction in capital, share transfer or liquidation to the SPV, or from engaging in other transfers of funds into or out of China.



We have advised our shareholders who are
PRC residents, as defined in Circular 75, to register with the relevant branch of SAFE, as currently required, in connection with
their equity interests in us and our acquisitions of equity interests in our PRC subsidiary and affiliate. However, we cannot provide
any assurances that their existing registrations have fully complied with, and they have made all necessary amendments to their
registration to fully comply with, all applicable registrations or approvals required by Circular 75. Moreover, because of uncertainty
over how Circular 75 will be interpreted and implemented, and how or whether SAFE will apply it to us, we cannot predict how it
will affect our business operations or future strategies. For example, our present and prospective PRC subsidiary’s and affiliate’s
ability to conduct foreign exchange activities, such as the remittance of dividends and foreign currency-denominated borrowings,
may be subject to compliance with Circular 75 by our PRC resident beneficial holders. In addition, such PRC residents may not always
be able to complete the necessary registration procedures required by Circular 75. We also have little control over either our
present or prospective direct or indirect shareholders or the outcome of such registration procedures. A failure by our PRC resident
beneficial holders or future PRC resident shareholders to comply with Circular 75, if SAFE requires it, could subject these PRC
resident beneficial holders to fines or legal sanctions, restrict our overseas or cross-border investment activities, limit our
subsidiary’s and affiliate’s ability to make distributions or pay dividends or affect our ownership structure, which
could adversely affect our business and prospects.



Because our funds are held in
banks that do not provide insurance, the failure of any bank in which we deposit our funds could affect our ability to continue
our business operations.



Banks and other financial
institutions in the PRC do not provide insurance for funds held on deposit. As a result, in the event of a bank failure, we may
not have access to funds on deposit. Depending upon the amount of money we maintain in a bank that fails, our inability to access
our cash could impair our operations, and, if we are not able to access funds to pay our suppliers, employees and other creditors,
we may be unable to continue our business operations.



10







Risks Related to Our Ordinary Shares.



We may not be able to pay any
dividends on our ordinary shares.



Under British Virgin Islands
law, we may pay dividends if we are able to satisfy the solvency test laid out in the BVI Business Companies Act, 2004, or the
BVI Act, which provides that directors must declare that immediately following the payment of a dividend or distribution the Company
would be solvent on both a cash flow and balance sheet basis. Our ability to pay dividends will therefore depend on our ability
to generate sufficient profits. We cannot give any assurance that we will declare dividends of any amounts, at any rate or at all
in the future. Future dividends, if any, will be at the discretion of our board of directors and will depend upon our results of
operations, our cash flows, our financial condition, the payment of our subsidiaries of cash dividends to us, our capital needs,
future prospects and other factors that our directors may deem appropriate. We have never declared or paid any dividend on our
ordinary shares and we do not anticipate paying any dividends on our ordinary shares in the future.



There is no public market for
our ordinary shares, and you may not be able to resell our ordinary shares at or above the price you paid, or at all.



There is no public market
for our ordinary shares. If an active trading market for our ordinary shares does not develop, the market price and liquidity of
our ordinary shares will be materially and adversely affected and you may not be able to resell our ordinary shares at or above
the price you paid, or at all. An active trading market for our ordinary shares may not develop in a timely manner or at all.



ITEM
4.	INFORMATION ON THE COMPANY



| | 4A. | History and Development of the Company
| | --- | --------------------------------------



We are a limited liability company organized
on January 5, 2010 under the BVI Business Companies Act, 2004 of the British Virgin Islands. We were organized under the name Glorious
Pioneer Investments Ltd., as a blank check company for the purpose of acquiring, through a share exchange, asset acquisition or
other similar reverse acquisition, an operating business. On December 28, 2012 we completed such an acquisition.



Reverse Acquisition



On November 1,
2012, Easy Health and its sole shareholder entered into a share exchange agreement with Oriental Honour and the shareholders of
Oriental Honour. Pursuant to the share exchange agreement, on December 28, 2012 Easy Health acquired from the shareholders of Oriental
Honour all of the issued and outstanding shares of Oriental Honour, in exchange for 15,000,000
newly issued ordinary shares issued by Easy Health to the shareholders of Oriental Honour. In addition, the sole shareholder of
Easy Health sold all of the 5,000,000 ordinary shares of Easy Health that were issued and outstanding prior to the reverse acquisition,
to the shareholders of Oriental Honour for $450,000 (which is equal to $0.09 per share) in cash. As a result, the individuals and
entities that owned shares of Oriental Honour prior to the reverse acquisition acquired 100% of the equity of Easy Health, and
Easy Health acquired 100% of the equity of Oriental Honour. Oriental Honour is now a wholly owned subsidiary of Easy Health. In
anticipation of the reverse acquisition, Easy Health filed an amended charter, pursuant to which Easy Health changed its fiscal
year end to July 31, changed the par value of its ordinary shares to $0.01 per share and increased its authorized shares to 100,000,000.
Upon the consummation of the reverse acquisition, we ceased to be a shell company.



11







Our Shareholders



The following individuals
and entities were shareholders of Oriental Honour prior to the reverse acquisition:



|                                        |  | Shares of Easy Health Acquired |           |  | Percentage of Outstanding Shares |  |      | Affiliation, other than as Shareholder
|--------------------------------------- |  | ------------------------------ | --------- |  | -------------------------------- |  | ---- | --------------------------------------
|Mark Time Development Limited(1)        |  |                                | 8,344,000 |  |                                  |  | 41.7 | %                                     
|Mascot Fortune International Limited(2) |  |                                | 2,896,000 |  |                                  |  | 14.5 | %                                     
|Industrial Express Limited(2)           |  |                                | 2,000,000 |  |                                  |  | 10.0 | %                                     
|Songlin Su                              |  |                                | 680,000   |  |                                  |  | 3.4  | %                                     
|Guangxing Gao                           |  |                                | 680,000   |  |                                  |  | 3.4  | %                                     
|Other Investors(3)                      |  |                                | 5,400,000 |  |                                  |  | 27.0 | %                                     



| | (1) | Wu Sixiang has exclusive authority to vote and dispose of the shares held by Mark Time Development
Limited.
| | --- | -----------------------------------------------------------------------------------------------------------



| | (2) | Wu Liangbiao has exclusive authority to vote and dispose of the shares held by Mascot Fortune International
Limited and the shares held by Industrial Express Limited. Lingxiang Zhang, the owner of 90% of the registered equity of Anshan
Easy Health Technology Development Co., Ltd., is the niece of Wu Liangbiao.
| | --- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | (3) | The holders of the remaining 27% of our shares are seven investors, each owning less than 5% of our
outstanding shares, who are residents of the PRC and are unaffiliated with us.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Our Subsidiaries



Hong Kong Company



Oriental Honour, our wholly
owned subsidiary, was incorporated on July 28, 2011 under the laws of the Hong Kong. We acquired all of the capital stock of Oriental
Honour pursuant to the reverse acquisition on December 28, 2012. As a result of the transaction, Oriental
Honour is a wholly owned subsidiary of Easy Health. Oriental Honour owns the registered equity of Jinwo (Shanghai) Information
Technology Co., Ltd. (“Jinwo Shanghai”).



PRC WFOE



Jinwo Shanghai was organized
on May 10, 2012 in the PRC as a wholly foreign-owned entity. As described below, Jinwo Shanghai controls the operations of Anshan
Easy Health, our PRC operating company, through a set of agreements known as the “VIE Agreements.”



PRC Operating Company



Anshan Easy Health is
was organized in Liaoning Province, PRC on March 9, 2012. Ms. Lingxiang Zhang and Mr. Song Gu together own 100% of the registered
equity of Anshan Easy Health, having contributed 1,000,000 RMB ($158,479) to the capital of Anshan Easy Health. Ms. Zhang owns
90% of Anshan Easy Health and Mr. Gu owns 10%. Anshan Easy Health carries on all of our business operations.



VIE Agreements



Ms. Lingxiang Zhang and
Mr. Song Gu, along with Anshan Easy Health and Jinwo Shanghai, entered into a set of contracts on July 2, 2012 that provide Jinwo
Shanghai with effective control over the operations of Anshan Easy Health and assign the economic benefits and responsibilities
of Anshan Easy Health to Jinwo Shanghai in consideration for the services provided by Jinwo Shanghai.  Each of the agreements
has a term of 30 years. However, we intend to continue this business arrangement upon the expiration of these contractual arrangements
by renewing such agreements or entering into new, similar contractual arrangements, unless the then current PRC law allows us to
directly operate Anshan Easy Health’s business in China.



12







Below is a summary of
the five agreements that depict the VIE relationship of Anshan Easy Health with Jinwo Shanghai, with the result that their financial
condition and results of operations will be consolidated on the financial statements of the Company.



Exclusive Business
Cooperation Agreement.  Pursuant to the Exclusive Business Cooperation Agreement entered into on July 2, 2012 between
Jinwo Shanghai and Anshan Easy Health, Jinwo Shanghai provides technical and consulting services related to the business operations
of Anshan Easy Health, including management consultation, staff training, business support, financial consulting and related services.
Among other things, Jinwo Shanghai has assumed responsibility for all management functions, all labor matters, all financial controls,
all contract matters, and all financing matters. As consideration for such services, Anshan Easy Health agreed to pay an annual
service fee to Jinwo Shanghai equal to 100% of its net income for such year.  The term of this agreement is 30 years from
the date thereof. Anshan Easy Health may terminate the agreement upon Jinwo Shanghai’s gross negligence or commission of
a fraudulent act against Anshan Easy Health.  Jinwo Shanghai may terminate the agreement at any time upon giving 30 days’
prior written notice to Anshan Easy Health.



Exclusive Option
Agreement.    Jinwo Shanghai entered into an exclusive option agreement on July 2, 2012 with the shareholders
of Anshan Easy Health, Messrs. Zhang and Gu, as well as Anshan Easy Health itself, pursuant to which Jinwo Shanghai has an exclusive
option to purchase, or to designate another qualified person to purchase, to the extent permitted by PRC law and foreign investment
policies, part or all of the equity interests in Anshan Easy Health owned by Ms. Zhang and Mr. Gu.  To the extent permitted
by the PRC laws, the purchase price for the entire equity interest shall equal the actual capital contributions paid into the registered
capital of Anshan Easy Health by each of the Anshan Easy Health shareholders. The exclusive option agreement has a 30 year term.



Share Pledge Agreement. 
  Pursuant to share pledge agreements dated July 2, 2012, each of Ms. Zhang and Mr. Gu pledged her/his equity interest
in Anshan Easy Health to Jinwo Shanghai to secure Anshan Easy Health’s obligations under the exclusive business cooperation
agreement described above. In addition, the shareholders of Anshan Easy Health agreed not to transfer, sell, pledge, dispose of
or create any encumbrance on any equity interests in Anshan Easy Health that would affect Jinwo Shanghai’s interests. The
share pledge agreement will expire when Anshan Easy Healthfully performs its obligations under the exclusive business cooperation
agreement. We are in the process of registering the share pledges with the local Administration of Industry and Commerce branch
in the PRC.



Powers of Attorney. 
  Ms. Zhang and Mr. Gu each signed a power of attorney dated July 2, 2012 providing Jinwo Shanghai the power to act as
her/his exclusive agent with respect to all matters related to his/her ownership of Anshan Easy Health, including the right to
attend shareholders’ meetings of Anshan Easy Health and the right to exercise voting rights to which she/he is entitled under
PRC law.



Organizational Structure
Chart



The following chart reflects
our organizational structure after the reverse acquisition between Oriental Honour and Easy Health:



13













Registered
office - British Virgin Islands



The address of our registered
office in the British Virgin Islands is: Akara Building, 24 De Castro Street, Wickhams Cay 1, Road Town, Tortola, British Virgin
Islands. The telephone number of the registered office is (284) 494-4840.



4B. Business Overview



Overview



The individuals who organized our company
have developed an electrical medical diagnostic device that will enable our customers to obtain low cost, rapid diagnosis of a
wide array of adverse health conditions. The device incorporates knowledge from a number of disciplines: Chinese Meridian theory
- the measurement of the flow of life energy (“qi”) - as well as 21st Century western medicine, advanced
statistical analysis, and electronics. Nevertheless, the device is manufactured for us at a relatively low cost. The low cost of
the device, combined with the availability of a portable data collector, provide us a vehicle for rapid distribution of our diagnostic
services, for both home and office-based applications, throughout China.



14







Our business plan contemplates that our
company will serve as a relatively small and flexible hub for the network of independent parties that will participate in the distribution
of diagnostic services to our clientele. The primary spokes on the network will be:



| | · | Manufacturing. We have contracted with a well-established medical
equipment manufacturer to produce the devices to our order.
| | - | -----------------------------------------------------------------------------------------------------------------------------



| | · | Marketing.A network of exclusive regional agents will solicit
clients for our diagnostic services and perform the diagnostic services utilizing our device.
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------
| |   |                                                                                                                                                            

| | · | Health Care Services.A major health care provider has contracted
to provide post-diagnosis, health care consultation and medical services to our clientele, and to provide hospital services as
needed.
| | - | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



This combination, in which we outsource
all but the central management function, is intended to enable us to achieve wide penetration for our diagnostic services with
only modest capital investment. We expect the initial capital contribution of $1.5 million to Anshan Easy Health will be adequate
to finance our business operations at the initial stage.



The Tele Diagnostic System



The
foundation for our business is a theTeleDiagnosis System (“TDS”), a non-invasive, electronic diagnostic device
that can assess a wide range of human health conditions accurately within ten minutes. The technological foundation for the TDS
is the theory of biomechanical impulses, first given practical application by Professor William Einthoven, who received the Nobel
Prize for his development in 1903 of a practical device to diagnose cardiac issues by analyzing surface bio-electric impulses -
i.e. the electrocardiograph. Currently western medical practitioners carry our electrical diagnosis of a range of maladies is carried
out through a variety of devices, including ECG diagnosis, EEG diagnosis, EGG diagnosis, ERG diagnosis and so on.



Our device incorporates the principles underlying
the electrocardiogram, but combines them with the Meridian theory that is at the root of much traditional Chinese medicine - the
theory that life-energy nourishes the body’s organs by travelling through a network of meridians that connect organs and
extremities. Combining the principles from these two traditions allows us to offer clients a broader array of targets for diagnosis
than is the focus of either tradition individually.



The diagnostic test is performed by a technician
trained by Anshan Easy Health to understand and operate the TDS. The places where the tests are performed must be quiet with no
electromagnetic interference. The technician initially collects basic medical information from the client: gender, age, height,
weight, blood pressure, the current state of health and disease, family history, lifestyle (diet, physical activity, smoking, alcohol
consumption, etc.), and hematic laboratory tests (blood lipids, blood sugar, etc.). After the technician inputs the client’s
information into the TDS, the acupoints of the examinees on which the tests will be conducted are wiped with a cotton ball with
0.9% sodium chloride. Moving from the client’s right side to the left side, the testing staff collects data on 24 bioelectrical
collection points with a non-invasive probe. After the data input is complete, the testing staff logs onto a central database that
provides an interpretive data report for the client. The entire process takes 3-5 minutes to complete.



Our proprietary software interprets the
client’s data by comparison to data models. The Anshan Easy Health database system consists of three parts: the terminal
testing equipment, the central database and the test report. The terminal testing equipment collects bioelectrical values at specific
points on the client’s skin and transfers the values into digital signals in TDS measurement units. The signals are uploaded
to the central database, where a large number of normal human bioelectrical data models and individual specific-state bioelectrical
data models are stored. The models are updated continuously following the principles of evidence-based medicine, providing a frame
of reference for detecting a variety of common diseases. When the data submitted by the terminal testing equipment achieves a certain
degree of similarity with a pre-existing data model, the system will analyze the disease status, make a preliminary judgment on
potential diseases, make a preliminary screening on cancer risk, and make a comprehensive assessment of the overall condition of
the client’s body. After the central database completes the assessment of the client’s bioelectric signals, it will
send its conclusions and the relevant health warnings to the terminal testing equipment, which will generate a test report for
the client.



15







Included in the comparative
analysis performed by the TDS database of the overall health status of the client are the following procedures:



| | 1. | an assessment of the nine basic states of the body, including physical, metabolic status, the spirit of the neural activity
state, and the state of motion;
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | a diagnosis or diagnostic warning of nearly 60 types of common diseases/healthy problems, including:
gastritis, cervical spondylosis,lumbar vertebrae disease,
insufficiency of cardiovascular and cerebrovascular blood supply, bad gallbladder contraction and autonomic dysfunction;
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 3. | an early warning analysis for coronary heart disease, stroke, liver disease, diabetes, and cancer;
| | -- | --------------------------------------------------------------------------------------------------



| | 4. | a diagnostic warning on more than 30 types of diseases diagnosable by Chinese traditional medical doctors, such as: liver yang
hyperactivity, deficiency of lung qi, stomach hotness, dampness-heat of bladder, and yin deficiency of spleen and kidney.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                                                                                                         

| | 5. | the TDS database can also categorize nine kinds of constitution/physical type, such as qi-insufficiency
constitution, damp-heat constitution, blood insufficiency constitution and peace/balance constitution.
| | -- | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Quality control over the
TDS is maintained by an ongoing program of sampling and testing. Anshan Easy Health has engaged a number of hospitals to function
as independent third party reviewers of the diagnostic results produced by the TDS. The hospitals examine the client and then review
the diagnostic report provided to the client by Anshan Easy Health to determine its accuracy. To date, the rate of consistency
between the TDS diagnoses and the clinical diagnoses has exceeded 80%.



The hardware component
of the TDS is manufactured for us by Fuzhou Fobes, an experienced fabricator of medical devices. The Cooperation Agreement that
we signed with Fuzhou Fobes on May 29, 2012 includes the following terms:



| | · | For a term of five years Fuzhou Fobes will manufacture the TDS exclusively for Anshan Easy Health.
| | - | --------------------------------------------------------------------------------------------------



| | · | The purchase prices payable by Anshan Easy Health will be 20,000 RMB ($3,170) for a complete office-based
system and 2,000 ($317) for a portable data collection unit.
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | Anshan Easy Health has committed to the following minimum annual purchases: 2012: 500,000 RMB ($79,239);
2013: 1,000,000 RMB ($158,479); 2014 - 2016: 1,500,000 RMB ($237,718).
| | - | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | In the event of default, liquidated damages are stipulated, equal to 10% of the prior year’s
purchases.
| | - | -------------------------------------------------------------------------------------------------------



| | · | Fuzhou Fobes provides a five year repair or replace warranty.
| | - | -------------------------------------------------------------



Membership



Our method of recruiting
clients for our diagnostic services centers on the sale of membership cards. We are developing a network of regional sales agents,
who will be responsible for client solicitation and delivery of the TDS services. Each sales agent commits to purchase membership
cards from us, which it then distributes at fixed prices in its region. We sell a standard one year Easy Health membership card
to our agent for 600 RMB ($95), and the agent resells it for 800 RMB ($127). We also offer a VIP membership card, purchased by
our agent for 2,400 RMB ($380) and resold for 3600 RMB ($571). Both memberships offer the client comprehensive diagnostic services,
including:



16







| | · | TDS diagnosis.Based
on the collection of personal health information, quantitative assessment of an individual's health state and the risk of future
illness or death is conducted in a mathematical model and then the status of the individuals in the "health", "mild
sub-health", "severe sub-health" or "disease" is determined;
| | - | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | Health Management Consulting. After the completion of the physical examination and TDS health
assessment, our client may receive different levels of health advisory services. Our client may go to a health management service
center to receive counseling, or communicate by telephone with a personal health administrator. The consultation includes explanation
of the personal health information, the health assessment results, and the effects to our customers’ health. The consulting
professional will also assist the client in making personal health management plans, provide health guidance, and make follow-up
plans.
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | General Health Service. The follow-up health services vary, depending on the situation of our
clients. Our clients have access to personal health information on the internet and receive health guidance. We regularly send
our customers communications regarding health management and health tips and provide personalized health improvement plans.
| | - | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | Specific Health and Disease Management Services.Our customers who have chronic diseases can choose specific services for a specific disease or disease risk factors, such
as diabetes management, cardiovascular disease management, stress relief, smoking cessation, exercise, nutrition and dietary counseling.
Optional services include personal health education, lifestyle improvement consulting and education.
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Purchase of a standard
one year Easy Health membership card entitles the holder to the following:



| | · | two TDS diagnostic sessions with the follow-on evaluations and recommendations;
| | - | -------------------------------------------------------------------------------



| | · | free online health counseling provided by the China Health Management Center Network (www.12021.cn);
| | - | ----------------------------------------------------------------------------------------------------



| | · | green channel service and favorable pricing when visiting doctors in the medical institutions that are affiliated with Anshan
Easy Health;
| | - | ------------------------------------------------------------------------------------------------------------------------------------------
| |   |                                                                                                                                           

| | · | life-long health records.
| | - | -------------------------



Purchase of a one year
VIP Easy Health membership card entitles the holder to these additional privileges:



| | · | four TDS diagnostics sessions.
| | - | ------------------------------



| | · | free consultation, twice a year, conducted by specialists in a 3 Grade Class A Hospital in a major
city in China;
| | - | -----------------------------------------------------------------------------------------------------------------



| | · | one annual doctor visit or hospitalization in a 3 Grade Class A Hospital in a major city in China.
| | - | --------------------------------------------------------------------------------------------------



Marketing Network



We intend
to rely on exclusive regional agents to market our services. To date, Anshan Easy Health has entered into regional agency agreements
with agents in the TieDong District of Anshan City, the TieXi District of Anshan City, Fujian Province, Fushun (Liaoning Province)
and Jinan (Shandong Province). Each regional agent enters into an agency agreement that contains the following basic terms:



| | · | The agent will purchase membership cards at set prices and resell them at a 33% markup.
| | - | ---------------------------------------------------------------------------------------



| | · | For every 1000 membership cards purchased, Anshan Easy Health will provide the agent one
office-based TDS system and two portable data collection devices.
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------------



17







| | · | Anshan Easy Health will train the agent’s personnel to enable them to administer the
TDS test. For each diagnostic test administered by the agent, Anshan Easy Health will pay 40 RMB ($6.35) to Fuzhou Fobes and Fuzhou
Fobes in turn will pay 30 RMB ($4.75) to the agent who performed the diagnostic test. Fuzhou Fobees will retain 10RMB as compensation
for equipment maintenance and consulting.
| | - | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | · | To maintain its agency, the agent must meet set targets for annual sales. Our two initial
agents, for example, are required to meet the following sales targets: to sell the membership cards worth no less than 1.0 million
RMB ($158,730) in the first year; no less than 2.0 million RMB ($317,460) in 2013; and no less than 3.0 million RMB ($476,190)
in each year from 2014 to 2016. If two consecutive quarters of sales amount to less than 300,000 RMB ($47,619), we are entitled
to revoke the agency.
| | - | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Each of the five regional
agents engaged to date has purchased its initial inventory of 1,000 membership cards. In turn, since August Anshan Easy Health
has purchased 11 office-based TDS sets and 22 portable TDS data collection units, some for delivery to the initial agents, others
to have available as new agents are brought on.



Medical Services



Anshan Easy Health does not employ doctors
or directly offer medical care to its clients. To meet the needs of clients whose TDS diagnosis indicates a need for medical care,
Anshan Easy Health has associated with the China Primary Health Care Foundation, a non-profit organizationco-founded by
the Chinese Peasants and Workers Democratic Party and the PRC Ministry of Health for the purpose of funding and developing the
primary health care task in China's poverty-stricken areas. China Primary Health Care Foundation is a supporter of a large-scale
public welfare activity, "Chinese Enterprises Health Miles,” and Anshan Easy Health is one of the partners in the abovementioned
welfare activity.



The specific medical services provided to
Anshan Easy Health’s clients are made available by Dayi Jingcheng (Beijing) Hospital Management Co. (“Dayi”)
which is a cooperative partner of the China Primary Health Care Foundation. In June 2012 Anshan Easy Health entered into a Service
Agreement with Dayi, which provides that Dayi will arrange consultation conducted by specialists/doctors and hospitalization in
a 3 Grade Class-A Hospital for Anshan Easy Health’s members. Dayi also provides Anshan Easy Health with specialists’
service on www.12021.cn. Anshan Easy Health pays Dayi for its services up to the limits afforded to members - i.e. one annual hospital-based
doctor visit, one annual hospitalization, and online or telephonic consultation as needed.



Competition



We are not aware of any company currently
providing electromagnetic medical diagnostic services on an out-patient basis in China. In China, this type of medical diagnostic
equipment is mainly used in hospitals at all levels, such as MRI, CT, ECG, EEG, EGG, ERG map. We expect clients to choose our services
as an alternative to hospital-based diagnosis mainly because of the convenience.



We expect that if we are successful in this
business, competitors will arise. Our plan for successful competition will be to focus on the technological advantages of our proprietary
software system. While our hardware could be readily duplicated, the hardware device is mainly a bio-signal collection tool to
obtain the bioelectrical value of the specific surface points of examinees. Our core technology and competitive advantage lie in
the central database and the test report. In the future, the Company plans to strengthen our research and development activities
so as to enhance the applicability and accuracy of the software. Medical diagnosis is an area in which quality is the primary competitive
advantage. So we plan to offer the quality of our TDS as our core competitiveness.



Governmental Regulations



Our
business will be subject to government regulation in several aspects:



Business license



Any company that conducts
business in the PRC must have a business license that covers a particular type of work. Our business license covers our present
business of performing electromagnetic diagnosis. Prior to expanding our business beyond that of our business license, we would
be required to apply and receive approval from the PRC government.



18







Employment laws



We are subject to laws
and regulations governing our relationship with our employees, including wage and hour requirements, working and safety conditions,
citizenship requirements, work permits and travel restrictions. These include local labor laws and regulations, which may require
substantial resources for compliance. China’s National Labor Law, which became effective on January 1, 1995, and China’s
National Labor Contract Law, which became effective on January 1, 2008, permit workers in both state and private enterprises in
China to bargain collectively. The National Labor Law and the National Labor Contract Law provide for collective contracts to be
developed through collaboration between the labor union (or worker representatives in the absence of a union) and management that
specify such matters as working conditions, wage scales, and hours of work. The laws also permit workers and employers in all types
of enterprises to sign individual contracts, which are to be drawn up in accordance with the collective contract.



Value added tax



Pursuant to the Provisional
Regulation of China on Value Added Tax and their implementing rules, all entities and individuals that are engaged in the sale
of goods, the provision of repairs and replacement services and the importation of goods in China are generally required to pay
VAT at a rate of 17.0% of the gross sales proceeds received, less any deductible VAT already paid or borne by the taxpayer. Furthermore,
when exporting goods, the exporter is entitled to a portion, or in some instances all, of the VAT refund that the exporter previously
paid.



Mandatory statutory
reserve and dividend distributions



Under applicable PRC regulations,
foreign-invested enterprises in China may pay dividends out of their accumulated profits only, if any, as determined in accordance
with PRC accounting standards and regulations. In addition, a foreign-invested enterprise in China is required to set aside at
least 10% of its after-tax profit based on PRC accounting standards each year for its general reserve until the cumulative amount
of such reserve reaches 50% of its registered capital. These reserves are not distributable as cash dividends. The board of directors
of a foreign-invested enterprise has the discretion to allocate a portion of its after-tax profits to staff welfare and bonus funds,
which may not be distributed to equity owners except in the event of liquidation.



4C. Organizational Structure



See “—History
and Development of the Company” above in subsection A of Item 4 for a description of our organizational structure.



4D. Property, Plants and Equipment



We entered into a lease on March 18, 2012
with Chunyang Xie for office space located in Anshan City, Liaoning Province, with an area of 247 square meters. The lease is for
a three year term, which terminates on March 17, 2015. The annually rent is $11,041. We use this space as office space and our
headquarters. At the conclusion of the lease we have the option, with one month notice, to negotiate a lease renewal.



ITEM
4A.	      UNRESOLVED STAFF COMMENTS



Not applicable



19







|ITEM 5. | OPERATING AND FINANCIAL REVIEW AND PROSPECTS
|------- | --------------------------------------------



| | 5A. | Operating Results
| | --- | -----------------





Accounting for Reverse Acquisition



On December 28, 2012 the Company acquired ownership of the outstanding
shares of Oriental Honour International Group Limited (“Oriental Honour”). In connection with the acquisition, control
of the Company was transferred to the prior owners of Oriental Honour. In addition, the fundamental nature of the Company’s
business was changed, as the Company had been a shell prior to the acquisition and became involved in the business of providing
medical diagnostics after the acquisition, utilizing the assets of, and business relationships developed by, an entity controlled
by Oriental Honour. For these reasons, for accounting purposes, the acquisition of Oriental Honour has been treated as a recapitalization
with no adjustment to the historical basis of its assets and liabilities.  The restructuring has been accounted for using
the “as if” pooling method of accounting and the operations were consolidated as if the restructuring had occurred
as of the beginning of the earliest period presented in our consolidated financial statements and the current corporate structure
had been in existence throughout the periods covered by our consolidated financial statements.



Accounting
for Variable Interest



Oriental Honour is a holding company whose only asset is a 100%
ownership interest in Jinwo (Shanghai) Information Technology Co., Ltd. (“Jinwo Shanghai”), a Wholly Foreign Owned
Entity organized under the laws of the PRC on May 10, 2012.  On July 2, 2012 Jinwo Shanghai entered into five agreements
with Anshan Easy Health Technology Development Co., Ltd. (“Anshan Easy Health”) and with the equity owners in Anshan
Easy Health.  Collectively, the agreements provide Jinwo Shanghai exclusive control over the business of Anshan Easy
Health.  The relationship is one that is generally identified as “entrusted management.”



The accounting effect of the Entrusted Management Agreements
between Jinwo Shanghai and Anshan Easy Health is to cause the balance sheets and financial results of Anshan Easy Health to be
consolidated with those of Jinwo Shanghai, with respect to which Anshan Easy Health is now a variable interest entity.





Period
from August 1, 2011 (Inception) to July 31, 2012



Oriental
Honour was organized on July 28, 2011. On May 10, 2012 Oriental Honour organized Jinwo Shanghai as a wholly-owned subsidiary. Prior
to July 2, 2012 neither Oriental Honour nor Jinwo Shanghai carried on any business operations. On July 2, 2012 Jinwo Shanghai entered
into the Entrusted Management Agreements and undertook obligation for management of Anshan Easy Health.



Anshan
Esay Health was organized on March 9, 2012. During the period from that date through the end of its fiscal year on July 31, 2012,
Anshan Easy Health was involved in developing the business relationships necessary for it to implement its business plan. During
this time, in particular, Anshan Easy Health established the relationships that will be central to its business, specifically:



| | · | Anshan Easy Health engaged its first two selling agents, and delivered to them their first
inventory of membership cards;
| | - | -------------------------------------------------------------------------------------------------------------------------



| | · | Anshan Easy Health entered into an agreement with Fuzhou Fobes, which is manufacturing the
testing equipment that the Company will consign to its selling agents; and
| | - | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
| |   |                                                                                                                                                                      

| | · | Anshan Easy Health entered into an agreement with China Health Management Center Network
to provide health counseling to members referred by Anshan Easy Health.
| | - | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



The
administrative expenses incurred by the consolidated entities during the period from July 2, 2012 to July 31, 2012 totaled $7,817,
which were Oriental Honour’s only operating expenses during that period. Oriental Honour also recorded $76 in other expenses
plus $32 in accrued taxes. Since Anshan Easy Health recorded no revenue for the period - the delivery of membership cards to our
agents was not sufficient performance to allow us to record revenue under U.S. GAAP - Oriental Honour recorded a net loss of $7,925
for the period from Inception to July 31, 2012.



Our reporting currency is the U.S. dollar.
Our local currency, the Renminbi (RMB), is our functional currency. Results of operations and cash flow are translated at average
exchange rates during the period, and assets and liabilities are translated at the unified exchange rate as quoted by the People’s
Bank of China at the end of the period. Translation adjustments resulting from this process are included in accumulated other comprehensive
income in the statement of stockholders’ equity. For the period from Inception to July 31, 2012, we recorded an other comprehensive
loss of $308 resulting from foreign currency translation adjustments.



20







5B.Liquidity
and Capital Resources



Oriental
Honour and Jinwo Shanghai were initially funded by contributions of $101,300, representing the aggregate registered capital of
those two entities. Anshan Easy Health was initially funded by a contribution of 10 million RMB ($1,583,983) to its registered
capital, made by Lingxiang Zhang and Song Gu. Since Anshan Easy Health had positive cash flow from initial operations and did not
begin to purchase testing equipment until after July 31, 2012, at that date the consolidated balance sheet of Oriental Honour showed
$1,701,659 in cash and $1,556,555 in working capital.



Anshan
Easy Health recorded positive cash flow from operating activities during the period ended July 31, 2012 because it had limited
expenses and generated cash by delivering membership cards to its agents. In July, Anshan Easy Health delivered membership cards
with a purchase price of $190,039 and received payment of $57,012 prior to the end of the month - the remainder of the payment
was made in August. Because the membership cards impose future service obligations on Anshan Easy Health, the delivery and payment
was not sufficient for Oriental Honour to record revenue under U.S. GAAP - the revenue will be recorded over the period when the
services are performed. Until recorded as revenue, the sale of the membership cards will be recorded as unearned revenue on Oriental
Honour’s consolidated balance sheet.



Anshan
Easy Health used only $435 in cash for purchase of property and equipment during the period ended July 31, 2012. Anshan Easy Health
has developed a business plan that will require relatively low upfront capital investment. Anshan Easy Health has outsourced all
of its manufacturing requirements, and so requires neither factory equipment nor sizeable realty. It will purchase testing equipment
as it engages sales agents - thereby associating each investment with an immediate source of revenue. It will also cause the testing
equipment to be delivered direct from the factory to the agent, thereby eliminating the need for an inventory warehouse.



The
standard regional agency agreement between Anshan Easy Health and a sales agent provides that Anshan Easy Health will deliver to
the agent one office-based set of diagnostic equipment and two portable units for each 1,000 membership cards purchased by the
agent. Anshan Easy Health’s cost for an office-based set is 20,000 RMB ($3,170); its cost for a portable unit is 2,000 RMB
($317). Its sales price for a membership card is 600 RMB ($95), with VIP cards selling for 2,400 RMB ($380). Assuming, for purposes
of this calculation, that only standard membership cards are sold, each investment of $3,804 by Anshan Easy Health in equipment
for an agent (one office-based set and two portable units) will be matched against $95,000 in membership sales.



Because
our business has only recently been initiated, we do not know whether or to what extent we will be able to maintain the ratio of
investment to sales described in the preceding paragraph, and still accomplish a widespread distribution of our services. If, however,
we are able to achieve or even approach that ratio, then our capital requirements will be modest, as we will be able to fund expansion
solely out of revenue. Our current level of working capital, therefore, should be adequate to sustain our operations for the foreseeable
future.



Critical Accounting
Policies and Estimates



In preparing our financial statements we
are required to formulate working policies regarding valuation of our assets and liabilities and to develop estimates of those
values.  In our preparation of the financial statements for the period ended July 31, 2012, there were no estimates made
which were (a) subject to a high degree of uncertainty and (b) material to our results.  However, Oriental Honour considers
the following accounting principles to be of particular importance.



Variable InterestEntity



For the reasons set forth in the introduction
to this Item, we will consolidate the financial condition and future results of operations of Anshan Easy Health in the Company’s
financial statements because Anshan Easy Health meets the definition of a variable interest entity set forth in ASC 810.



21







Revenue Recognition



Anshan Easy Health sells membership cards
to agents which sells them to the patients. TDS diagnostic service is provided by the agent to the patients. Anshan Easy Health
provides TDS equipment to agents for free.



Each patient may use TDS diagnosis service
twice a year. Anshan Easy Health recognizes revenue when a patient activates the card via network (www.12021.cn). The TDS diagnosis
can be performed at the agent’s office or by the mobile service offered by the agent at the patient’s home. When Anshan
Easy Health collects proceeds from sale of membership cards from agent, it records these proceeds as unearned revenue.



Recently Issued
Accounting Pronouncements



There were no recent accounting
pronouncements that have had a material effect on Anshan Easy Health’s financial position or results of operations.



5.C. Research and Development, Patents and Licenses, etc.



Neither
Oriental Honour nor Anshan Easy Health made any material expenditure on research and development activities during the period from
Inception to July 31, 2012.



5.D. Trend Information



Anshan
Easy Health has entered into regional agency agreements with agents in the TieDong District of Anshan City, the TieXi District
of Anshan City, Fujian Province, Fushun (Liaoning Province) and Jinan (Shandong Province).



5.E. Off-Balance Sheet Arrangements



We do not have any off-balance sheet arrangements
that have or are reasonably likely to have a current or future effect on our financial condition or results of operations.



5.F. Tabular Disclosure of Contractual Obligations



|                        |  | Payments due by Obligation |        
|----------------------- |  | -------------------------- | -------
|Contractual Obligations |  | Total                      |        
|Unearned Revenue        |  | $                          | 190,217
|Total                   |  | $                          | 190,217



|ITEM 6. | DIRECTORS, SENIOR MANAGEMENT, AND EMPLOYEES
|------- | -------------------------------------------



6.A. Directors and Senior Management



Since the date of our
reverse acquisition, the following individuals have served as our directors and executive officers:



|Name     |  | Positions                                      |  | Age
|-------- |  | ---------------------------------------------- |  | ---
|Wei Dong |  | Chairman of the Board, Chief Executive Officer |  | 48 
|Song Gu  |  | Vice President and Director                    |  | 30 



22







Mr. Wei Dong was
appointed as our Chairman, Chief Executive and Chief Technology Officer in March 2012. Since October 2006, Mr. Dong has been employed
as Vice General Manager of Beijing Renren Health and Technology Development Co., Ltd., mainly responsible for the company's technology
R&D and training of personnel. From 2006 until 2012, Mr. Dong also served as the Vice General Manager of Zhongjian Yikang (Beijing)
Technology Development Co., Ltd. From 2001 to 2006, Mr. Dong provided multiple entities, including Inner Mongolia Chiyu Science
Industry and Trade Group Corporation, Shanxi Fu Shan Pharmaceutical Group, Shanxi Taiyuan Pharmaceutical Group and Shanxi Ruifeng
Pharmaceutical Group Co., Ltd., with medical advice, training and marketing planning services. During this time period Mr. Dong
did promotional work for many pharmaceutical and health products, offered health information on dozens of broadcast media in China,
and presided over large-scale marketing and promotional activities for numerous health products. From 1987 until 2011, Mr. Dong
served as Resident Physician at People's Liberation Army No. 253 Hospital, engaging in multidisciplinary clinical work, participating
in and completing a number of professional research projects, and participating in a variety of professional training. In 1987
Mr. Dong graduated from the Second Military Medical University and obtained his bachelor’s degree in Medicine. Mr. Dong passed
the psychological counselor exam given by the Ministry of Labor and Social Security and obtained his qualification in psychological
counseling .



Mr. Song Gu was appointed as a director
and as our Vice President in March 2012. In 2010, he served as Manager of the Real Estate Department of Zhongrong International
Trust Co., Ltd. From 2009 to 2010, Mr. Gu served as Manager of the Customer Service Department of Beijing Renren Health and
Technology Industry Co., Ltd. From 2007 to 2008, Mr. Gu was a computer administrator for Bauer Druck Printer Factory in Germany.
Prior to that, from 2006 to 2007, he worked as profile administrator at AXA, a German insurance company. In 2009 Mr. Gu graduated
from Rheinische Fachhochschule BWL in Germany with a major in Economic Management. He graduated from Shoudu Technology College
in China in 2004 with a major in Computer Information Management.



Each of our directors
will serve as a director until our next annual meeting of shareholders and until his successor is duly elected and qualified.



There are no family relationships
between any of our directors or senior management. There are no arrangements or understandings with major shareholders, customers,
suppliers or others, pursuant to which any person referred to above was selected as a director or member of senior management.



6.B. Compensation



Director Compensation



Our directors do not currently
receive any cash compensation for their service as members of the board of directors.



Executive Compensation



Prior to the reverse acquisition,
no executive officer of Anshan Easy Health had received any cash compensation for services rendered to Easy Health.



The following table shows information concerning
the annual compensation that will be paid to executive officers of the Company during the current fiscal year:



|Name     |  | Year Ending July 31 |      |  | Salary |   |     | Bonus |  |  | Total compensation | 
|-------- |  | ------------------- | ---- |  | ------ | - | --- | ----- |  |  | ------------------ | 
|Wei Dong |  |                     | 2013 |  |        | $ | 555 |       |  |  | —                  | 
|Song Gu  |  |                     | 2013 |  |        | $ | 507 |       |  |  | —                  | 



Anshan Easy Health has no equity or long-term
compensation plans.



Employment Agreements



We have entered into employment
agreements with Messrs. Wei Dong and Song Gu. Mr. Dong is employed as Chief Technology Officer; Mr. Gu is employed as Vice President
of our Company. The term of both agreements is three years from March 8, 2012 until March 9, 2015. Mr. Dong’s agreement calls
for a monthly salary of 3,500 RMB ($555); Mr. Gu’s agreement calls for a monthly salary of 3,200 RMB ($507). Each is entitled
to an overtime premium of 50% for work in excess of eight hours per day and to a 100% premium for work on weekends. Anshan Easy
Health may terminate the agreements under the limited circumstances permitted by Chinese labor laws.



23







6.C. Board Practices



Board
Composition and Terms of Directors and Officers



Our board of directors
currently consists of two directors: Mr. Wei Dong and Mr. Song Gu, neither of whom qualifies as an independent director.



Pursuant to our memorandum
and articles of association, the business of our company is managed by our board of directors. Commencing with the first annual
meeting of the shareholders, directors are elected for a term of office to expire at the next succeeding annual meeting of the
shareholders after their election. Each director holds office until the expiration of his or her term of office and until his or
her successor has been elected and qualified, or until his or her earlier death, resignation or removal by resolution of shareholders
or a resolution of directors in accordance with the memorandum and articles of association.



The directors may at any
time by resolution of directors appoint any person to be a director to fill a vacancy. There is a vacancy if a director dies or
otherwise ceases to hold office as a director. The directors may not appoint a director to fill a vacancy for a term exceeding
the term that remained when the person ceasing to be a director ceased to hold office.



Our officers are appointed
by resolution of our directors and hold office until removed from office by our directors, whether or not a successor is appointed.



Committees
of the Board of Directors



We currently do not have any committees
under our board of directors.



Duties of Directors



Under the laws of the
British Virgin Islands, a director in exercising their powers or performing his or her duties shall act honestly and in good faith
and in what the director believes to be the best interests of the company. In fulfilling their duty of care to us, our directors
must ensure compliance with our Memorandum and Articles of Association. We have the right to take legal action if a duty owed by
our directors is breached.



We have not entered into
a director service contract with any of our directors



6.D. Employees



As of December 28, 2012,
we had seven full-time employees.



We have not experienced
any significant labor disputes and consider our relationship with our employees to be good. Our employees are not covered by any
collective bargaining agreement.



In accordance with applicable
PRC regulations, we maintain comprehensive insurance for our employees, including medical, accidental injury, maternity, and unemployment
insurance. We also contribute to an employee welfare plan and a housing public fund for the benefit of our employees. The aforesaid
benefits will cost 1,700 RMB ($269) per employee per annum during the current fiscal year.



As we continue to expand
our business, we believe it is critical to hire and retain top talent, especially in the areas of marketing, sales and brand management.
We believe we have the ability to attract and retain high quality talent in China based on our competitive salaries, annual performance-based
bonus system, and equity incentive program for senior employees and executives.



24







6.E. Share Ownership



Neither
Wei Dong nor Song Gu owns any securities issued by the Company.



Stock Options



We do not currently have
a stock option plan, nor are there any outstanding options to purchase securities issued by the Company.



ITEM
7.     	MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS



7.A. Major Shareholders



As of December 28, 2012,
20,000,000 of our ordinary shares were outstanding. Holders of our ordinary shares are entitled to vote together as a single class
on all matters submitted to shareholders for approval. No holder of ordinary shares has different voting rights from any other
holders of ordinary shares. We are not aware of any arrangement that may, at a subsequent date, result in a change of control of
our company. As of December 28, 2012, no ordinary shares were held by record holders resident in the United States.



Beneficial ownership is
determined in accordance with the rules and regulations of the SEC. Percentage of beneficial ownership of each listed person/entity
is based on ordinary shares outstanding as of December 28, 2012.



The following table sets
forth information with respect to the beneficial ownership of our common shares as of December 28, 2012 by:



| | · | each of our directors and executive officers; and
| | - | -------------------------------------------------



| | · | each person/entity known to us to beneficially own more than 5% of our outstanding ordinary shares.
| | - | ---------------------------------------------------------------------------------------------------



|Name of Beneficial Owner                          |  | Number of Shares |           |  | Percentage of Outstanding Shares | 
|------------------------------------------------- |  | ---------------- | --------- |  | -------------------------------- | 
|Wei Dong                                          |  |                  | 0         |  |                                  | 
|Song Gu                                           |  |                  | 0         |  |                                  | 
|All Officers and Directors as a Group (2 persons) |  |                  | 0         |  |                                  | 
|Mark Time Development Limited(1)                  |  |                  | 8,344,000 |  |                                  | 
|Mascot Fortune International Limited(2)           |  |                  | 2,896,000 |  |                                  | 
|Industrial Express Limited(2)                     |  |                  | 2,000,000 |  |                                  | 



_________________________________



| | (1) | Voting and dispositional control with respect to the shares owned by Mark Time International Limited
is held by Wu Sixiang.
| | --- | ---------------------------------------------------------------------------------------------------------------------------



| | (2) | Voting and dispositional control with respect to the shares owned by Mascot Fortune International
Limited and the shares owned by Industrial Express Limited is held by Wu Liangbiao.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



All of the shares currently
outstanding were acquired by the current shareholder in December 2012 in connection with the acquisition of Oriental Honour by
the Company.



25







7.B. Related Party Transactions



In March
2012 Lingxiang Zhang contributed RMB 9 million ($1,426,307) to the registered equity of Anshan Easy Health, and Song Gu contributed
RMB 1 million ($158,479) to the registered equity of Anshan Easy Health.



7.C. Interests of Experts and Counsel



None of the experts or
counselors named in this Report was employed on a contingent basis, owns any shares in the Company or its subsidiaries, or has
a material economic interest in the Company.



|ITEM 8. | FINANCIAL INFORMATION
|------- | ---------------------



Consolidated Statements and Other Financial
Information



The financial statements
required by this item may be found at the end of this report on 20-F.



Legal Proceedings



From time to time, we
may be involved in various claims and legal proceedings arising in the ordinary course of business. We are not currently a party
to any such claims or proceedings which, if decided adversely to us, would either, individually or in the aggregate, have a material
adverse effect on our business, financial condition, results of operations or cash flows.



Dividends



We have never declared
or paid any dividend on our ordinary shares and we do not anticipate paying any dividends on our ordinary shares in the future.
We currently intend to retain all future earnings to finance our operations and to expand our business.



No Significant Changes



No significant changes
to our financial condition have occurred since the date of the financial statements contained herein.



|ITEM 9. | THE OFFER AND LISTING
|------- | ---------------------



9.A. Offer and Listing Details



Not Applicable.



9.B. Plan of Distribution



Not Applicable.



9.C. Markets



Our ordinary shares are
not currently traded on any exchange.



9.D. Selling Shareholders



Not Applicable.



26







9.E. Dilution



Not Applicable.



9.F. Expenses of the Issue



Not Applicable.



Not Applicable.



|ITEM 10. | ADDITIONAL INFORMATION
|-------- | ----------------------



10. A. Share Capital



Authorized/Issued
Capital



The
authorized capital stock of the Company has, at all times, consisted of ordinary shares only. The following table provides information
regarding our ordinary shares as of the end of our last fiscal year and currently:



|                     |  | Authorized Shares |             |  | Par Value Per Share |   |      | Shares Issued and Fully Paid |  |  | Shares Issued But Not Fully Paid | 
|-------------------- |  | ----------------- | ----------- |  | ------------------- | - | ---- | ---------------------------- |  |  | -------------------------------- | 
|At July 31, 2012     |  |                   | 50,000      |  |                     | $ | 1.00 |                              |  |  | 9,088                            | 
|At December 28, 2012 |  |                   | 100,000,000 |  |                     | $ | .01  |                              |  |  | 20,000,000                       | 



The Company issued
50,000 ordinary shares to its original shareholder in 2010. These shares were split 100-for-1 when we amended our Memorandum
of Association to change in the par value of our shares from $1.00 to $0.01 on November 8, 2012. The holder of those 5,000,000
shares sold them to the former shareholders of Oriental Honour in connection with the acquisition of Oriental Honour by the
Company. In addition, we issued 15,000,000 new ordinary shares to the former shareholders of Oriental Honour in payment for
Oriental Honour.



Shares Not Representing
Capital



Not Applicable.



Shares Held By the
Company



Not Applicable.



Contingencies



There are no contracts,
resolutions, authorizations or approvals for the issuance of additional shares or the creation of new classes of shares.



10.B. Memorandum and Articles of Association



Charter



Our charter documents
consist of our amended and restated memorandum of association and our amended and restated articles of association, identified
in this Item as our memorandum and articles of association. We may amend our memorandum and articles of association generally by
a special resolution of our shareholders.



27







The following description
of certain provisions of our memorandum and articles of association does not propose to be complete and is qualified in its entirety
by our memorandum and articles of association included as Exhibit 3.1 to this prospectus.



Corporate Powers



Easy
Health was incorporated under theBVI Business Companies Act of 2004 (the “BVI Act”) on
January 5, 2010. Pursuant to our memorandum of association, the objects for which we were established are unrestricted and we have
full power and authority to carry out any objects not prohibited by the BVI Act, as the same may be revised from time to time,
or any other law of the British Virgin Islands (“BVI”), except that we have no power to carry on banking or trust business,
business as an insurance or reinsurance company, insurance agent or insurance broker, the business of company management, the business
of providing the registered office or the registered agent for companies incorporated in the BVI, or business as a mutual fund,
mutual fund management or mutual fund administrator, unless we obtain certain licenses under the laws of the BVI.



Board Composition



Pursuant to our memorandum
and articles of association, the business of our company is managed by our board of directors. Commencing with the first annual
meeting of the shareholders, directors are elected for a term of office to expire at the next succeeding annual meeting of the
shareholders after their election. Each director will hold office until the expiration of his or her term of office and until his
or her successor has been elected and qualified, or until his or her earlier death, resignation or removal by the shareholders
or a resolution passed by the majority of the remaining directors.



In the interim between
annual meetings of shareholders, or special meetings of shareholders called for the election of directors, any vacancy on the board
of directors may be filled by the vote of a majority of the remaining directors then in office, although less than a quorum, or
by the sole remaining director. A director elected to fill a vacancy resulting from death, resignation or removal of a director
will serve for the remainder of the full term of the director whose death, resignation or removal will have caused such vacancy
and until his successor will have been elected and qualified.



There is no cumulative
voting by shareholders for the election of directors. We do not have any age-based retirement requirement and we do not require
our directors to own any number of shares to qualify as a director.



Board Meetings



Board meetings may be
held at the discretion of the directors at such times and in such manner as the directors may determine upon not less than three
days notice having been given to all directors. Decisions made by the directors at meetings shall be made by a majority of the
directors. There must be at least a majority of the directors (with a minimum of two) at each meeting.



Directors Interested in a Transaction



A director must, immediately
after becoming aware of the fact that he is interested in a transaction entered into or to be entered into by us, disclose such
interest to the board of directors. A director who is interested in a transaction entered into, or to be entered into, by the company,
may vote on a matter related to the transaction, attend a meeting of directors at which a matter relating to the transaction arises
and be included among the directors present at the meeting for the purposes of a quorum and sign a document on behalf of the company,
or do any other thin in his capacity as a director, that relates to the transaction. A director is not required to disclose his
interest in a transaction or a proposed transaction to our board of directors if the transaction or proposed transaction is between
the director and us, or the transaction or proposed transaction is or is to be entered into the ordinary course of our business
and on usual terms and conditions.



28







The directors may exercise
all powers of our company to borrow money, mortgage or charge our undertakings and property, issue debentures, debenture shares
and other securities whenever money is borrowed or as security for any debt, liability or obligation of the company or of any third
party.



Our directors may, by
resolution, fix the compensation of directors in respect of services rendered or to be rendered in any capacity to us.



A director may attend
and speak at any meeting of the shareholders and at any separate meeting of the holders of any class of our shares.



Rights of Shares



We are currently authorized
to issue 100,000,000 ordinary shares. The shares are made up of one class and one series, namely ordinary shares with a par value
of $0.01 per share. The ordinary shares have one vote each and have the same rights with regard to dividends paid by the company
and distributions of the surplus assets of the company.



We may purchase, redeem
or acquire our shares, provided that we obtain the consent of the member whose shares are being purchased, redeemed or otherwise
acquired.



Issuance of Shares; Variation of Rights
of Shares



Our articles of association
provide that directors may, without limiting or affecting any right of holders of existing shares, offer, allot, grant options
over or otherwise dispose of our unissued shares to such persons at such times and for such consideration and upon such terms and
conditions as the directors may determine.



Without prejudice to any
special rights previously conferred on the holders of any existing shares or class of shares, we may issue shares, with such preferred,
deferred or other special rights or such restrictions, whether in regard to dividend, voting or otherwise, as the directors from
time to time may determine.



If we issue shares of
more than one class, we will further amend and restate our Memorandum and Articles of Association to reflect the rights attached
to any class (unless otherwise provided by the terms of issue of the shares of that class) as may be varied with the consent in
writing of the holders of not less than three-fourths of the issued shares of that class and the holders of not less than three-fourths
of the issued shares of any other class of shares which may be affected by such variation. The rights conferred upon the holders
of the shares of any class issued with preferred or other rights will not, unless otherwise expressly provided by the terms of
issue of the shares of that class, be deemed to be varied by the creation or issue of further shares ranking pari passu therewith.



Shareholders Meetings



Under our memorandum and
articles of association, we are required to hold an annual meeting of shareholders each year at such date and time determined by
our directors. Meetings of shareholders may be called pursuant to board resolution or the written request of shareholders holding
more than 30% of the votes of our outstanding voting shares. Written notice of meetings of shareholders must be given to each shareholder
entitled to vote at a meeting not fewer than 10 days prior to the date of the meeting, with certain limited exceptions. The written
notice will state the place, time and business to be conducted at the meeting. The shareholders listed in our share register on
the date prior to the date the notice is given shall be entitled to vote at the meeting, unless the notice provides a different
date for determining the shareholders who are entitled to vote.



A meeting of shareholders
held without proper notice will be valid if shareholders holding 90% majority of the total number of shares entitled to vote on
all matters to be considered at the meeting, or 90% of the votes of each class or series of shares where shareholders are entitled
to vote thereon as a class or series, together with an absolute majority of the remaining votes, have waived notice of the meeting
and, for this purpose, presence of a shareholder at the meeting is deemed to constitute a waiver. The inadvertent failure of the
directors to give notice of a meeting to a shareholder, or the fact that a shareholder has not received notice, will not invalidate
a meeting.



29







Shareholders may vote
in person or by proxy. No business may be transacted at any meeting unless a quorum of shareholders is present. A quorum consists
of the presence in person or by proxy of holders entitled to exercise at least 50% of the voting rights of the shares of each class
or series of shares entitled to vote as a class or series thereon and the same proportion of the votes of the remaining shares
entitled to vote thereon.



Changes in the Maximum Number
of Shares the Company is Authorized to Issue



Subject to the provisions
of the BVI Act, we may, by a resolution of shareholders, amend our memorandum and articles of association to increase or decrease
the number of shares authorized to be issued. Our directors may, by resolution, authorize a distribution by us at a time, of an
amount, and to any shareholders they think fit if they are satisfied, on reasonable grounds, that we will, immediately after the
distribution, satisfy the solvency test as set forth in the BVI Act, which requires that the value of a company’s assets
exceeds its liabilities, and the company is able to pay its debts as they fall due.



Indemnification



Subject to the provisions
of the BVI Act, we may indemnify any person who (a) is or was a party or is threatened to be made a party to any threatened, pending
or completed proceedings, whether civil, criminal, administrative or investigative, by reason of the fact that the person is or
was a director of our company; or (b) is or was, at our request, serving as a director of, or in any other capacity is or was acting
for, another company or a partnership, joint venture, trust or other enterprise, against all expenses, including legal fees, and
against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or
investigative proceedings.



10.C. Material Contracts



Cooperation Agreement



Anshan Easy Health entered
into a Cooperation Agreement on May 29, 2012 with Fuzhou Fobes, a manufacturer of health diagnosis instruments. The agreement terminates
on May 28, 2017. The agreement provides that Fuzhou Fobes will manufacture our TDS testing equipment to our order in accordance
with standards that we provide. Fuzhou Fobes provides a five year repair or replace warranty. The purchase prices that we pay to
Fuzhou Fobes will be 20,000 RMB ($3,170) for each office-based set of testing equipment and 2,000 RMB ($317) for each portable
unit. Anshan Easy Health committed to the following minimum annual purchases: 2012: 500,000 RMB ($79,239); 2013: 1,000,000 RMB
($158,479); 2014 - 2016: 1,500,000 RMB ($237,718). In the event of default, liquidated damages are stipulated, equal to ten percent
of the prior year’s purchases.



Service Agreement



Anshan Easy Health entered
into a Service Agreement on June 20, 2012 with Dayi Jingcheng (Beijing) Hospital Management Co. The agreement provides that Dayi
will provide services to members referred by Anshan Easy Health, including specialist consultations twice a year and, if required,
hospitalization in a 3-Grade Class A Hospital in Beijing, Shanghai or other major city. Dayi also provides Easy Health members
with the specialist services offered online through www.12021.cn.



Lease Agreement



We entered into a lease
on March 18, 2012 with Chunyang Xie for office space located in Anshan City, Liaoning Province, with a total area of 247 square
meters. The lease is for a three year term, which terminates on March 17, 2015. The annually rent is $11,041. We use this space
as office space and our headquarters. At the conclusion of the lease we have the option, with one month notice, to negotiate a
lease renewal.



30







Employment Agreements



We have employment agreements
with each member of our management. See Item 6.B – Compensation for a summary of the employment agreements.



VIE Agreements



SeeItem 4B - Business
Overviewfor a summary of the five variable interest entity agreements between Jinwo Shanghai and Anshan Easy Health and with
the equity owners in Anshan Easy Health.



10.D. Exchange Controls



British Virgin Islands



There are no exchange
control regulations imposed on us or our shareholders under BVI law.



The PRC



China regulates foreign currency exchanges
primarily through the following rules and regulations:



| | · | Foreign Currency Administration Rules of 1996, as amended; and
| | - | --------------------------------------------------------------



| | · | Administrative Rules of the Settlement, Sale and Payment of Foreign Exchange of 1996.
| | - | -------------------------------------------------------------------------------------



The Renminbi is not a freely convertible
currency at present. Under the current PRC regulations, conversion of Renminbi is permitted in China for routine current-account
foreign exchange transactions, including trade and service related foreign exchange transactions, payment of dividends and service
of foreign debts. Conversion of Renminbi for most capital-account items, such as direct investments, investments in PRC securities
markets and repatriation of investments, however, is still subject to the approval of the PRC State
Administration of Foreign Exchange, or SAFE. See Item 3.D “Risk Factors” for further discussion of the
limitations on exchange of the Renminbi.



Pursuant to the above-mentioned
administrative rules, foreign-invested enterprises, such as our PRC subsidiaries, may buy, sell and/or remit foreign currencies
for current account transactions at banks in China with authority to conduct foreign exchange business by complying with certain
procedural requirements, such as presentment of valid commercial documents. For capital-account transactions involving foreign
direct investment, foreign debts and outbound investment in securities and derivatives, approval from SAFE is a pre-condition.
Capital investments by foreign-invested enterprises outside China are subject to limitations and requirements in China, such as
prior approvals from the PRC Ministry of Commerce or from SAFE.



10.E. Taxation



The following summary
of the material tax consequences of an investment in our ordinary shares relevant to our shareholders is based upon laws and relevant
interpretations thereof in effect as of the date of this prospectus, all of which are subject to change, possibly with retroactive
effect. The discussion is not intended to be, nor should it be construed as, legal or tax advice to any prospective purchaser and
is not exhaustive of all possible tax considerations. This summary does not deal with all possible tax consequences relating to
an investment in our shares, and in particular does not deal with the tax consequences under U.S. federal, state and local tax
laws or under any non-PRC and non-BVI tax laws. You should consult your own tax advisors with respect to the consequences of the
acquisition, ownership and disposition of our shares.



31







BVI Taxation



All dividends, interests,
rents, royalties, compensations and other amounts paid by us are exempt from all forms of taxation in the BVI and any capital gains
realized with respect to any of our shares, debt obligations, or other securities are not subject to any form of taxation in the
BVI. No estate, inheritance, succession or gift tax, rate, duty, levy or other charge is payable under BVI law by persons who are
not persons resident in the BVI with respect to any of our shares, debt obligation or other securities. There are currently no
withholding taxes or exchange control regulations in the BVI applicable to us or our shareholders. Currently, there is no income
tax treaty, convention or reciprocal tax treaty regarding withholdings currently in effect between the United States and the BVI.
We will only be liable to pay payroll tax with respect to employees employed and working in the BVI. We do not currently have,
and do not intend to have in the near future, any employees in the BVI.



PRC Taxation



Under the former Income
Tax Law for Enterprises with Foreign Investment and Foreign Enterprises, any dividends payable by foreign-invested enterprises
to non-PRC investors were exempt from PRC withholding tax. In addition, any dividends payable, or distributions made, by us to
holders or beneficial owners of our shares would not be subject to any PRC tax, provided that such holders or beneficial owners,
including individuals and enterprises, were not deemed to be PRC residents under the PRC tax law and were not otherwise subject
to PRC tax.



On March 16, 2007, the
PRC National People’s Congress approved and promulgated a new PRC Enterprise Income Tax Law, which took effect as of January
1, 2008. Under the new tax law, enterprises established under the laws of non-PRC jurisdictions but whose “de facto management
body” are located in China are considered “resident enterprises” for PRC tax purposes. Under the implementation
regulations issued by the State Council relating to the new tax law, “de facto management body” is defined as the body
that has material and overall management control over the business, personnel, accounts and properties of an enterprise. In April
2009, the PRC State Administration of Taxation promulgated a circular to clarify the definition of “de facto management body”
for enterprises incorporated overseas with controlling shareholders being PRC enterprises. It remains unclear how the tax authorities
will treat an overseas enterprise invested or controlled by another overseas enterprise and ultimately controlled by PRC individual
residents as is in our case. Since substantially all of our management is currently based in China and may remain in China in the
future, we may be treated as a “resident enterprise” for the PRC tax purposes, in which case, we will be subject to
PRC income tax as to our worldwide income at a uniform income tax rate of 25%. In addition, the new tax law provides that dividend
income between qualified “resident enterprises” is exempt from income tax.



Moreover, the new tax
law provides that an income tax rate of 10% is normally applicable to dividends payable for earnings derived since January 1, 2008
to non-PRC investors who are “non-resident enterprises,” to the extent such dividends are derived from sources within
China. We are a BVI holding company and substantially all of our income is derived from dividends, if any, we receive from our
operating subsidiaries located in China. Thus, dividends payable to us by our subsidiaries in China may be subject to the 10% withholding
tax if we are considered as a “non-resident enterprise” under the new tax law.



Under the currently available
guidance of the new tax law, dividends payable by us to our shareholders should not be deemed to be derived from sources within
China and therefore should not be subject to withholding tax at 10%, or a lower rate if reduced by a tax treaty or agreement. However,
what the tax authorities in China will deem to constitute income derived from sources within China is currently unclear. In addition,
gains on the disposition of our shares should not be subject to PRC withholding tax. However, these conclusions are not entirely
free from doubt. In addition, it is possible that these rules may change in the future, possibly with retroactive effect.



10.F. Dividends and Paying Agents



The Company has no current
plans to pay dividends. The Company does not currently have a paying agent.



10.G. Statement by Experts



The consolidated financial
statements of Oriental Honour and Anshan Easy Health as of July 31, 2012 and for the period from August 1, 2011 (inception) to
July 31, 2012, included herein, have been audited by Goldman Kurland and Mohidin, LLP, independent registered public accounting
firm, as stated in their reports appearing herein, and is included in reliance upon the reports of such firm given upon their authority
as experts in accounting and auditing and their consent and authorization.



32







10.H. Documents on Display



The Company’s documents
can be viewed at its headquarters, located at: 16 219 Street, Anshan City, Liaoning, 114002, PRC. The Company is subject to the
informational requirements of the Securities Exchange Act of 1934, as amended, and will file reports, registration statements and
other information with the SEC. The Company’s reports, registration statements and other information can be inspected on
the SEC’s website at www.sec.gov and such information
can also be inspected and copies ordered at the public reference facilities maintained by the SEC at the following location: 100
F Street NE, Washington, D.C. 20549.



10.I. Subsidiary Information



Not Applicable.



|ITEM 11. | QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|-------- | ----------------------------------------------------------



Not
Applicable.



|ITEM 12. | DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES
|-------- | ------------------------------------------------------



Not Applicable.



PART
II



|ITEM 13. | DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES
|-------- | -----------------------------------------------



Not Applicable.



|ITEM 14. | MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS
|-------- | ----------------------------------------------------------------------------



Not Applicable.



|ITEM 15. | CONTROLS AND PROCEDURES
|-------- | -----------------------



Not Applicable.



|ITEM 16. | RESERVED
|-------- | --------



|ITEM 16A. | AUDIT COMMITTEE FINANCIAL EXPERT
|--------- | --------------------------------



Not Applicable.



|ITEM 16B. | CODE OF ETHICS
|--------- | --------------



Not Applicable.



|ITEM 16C. | PRINCIPAL ACCOUNTIING FEES AND SERVICES
|--------- | ---------------------------------------



Not Applicable.



|ITEM 16D. | EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES
|--------- | ----------------------------------------------------------



Not Applicable.



33







|ITEM 16E. | PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS
|--------- | ----------------------------------------------------------------------



Not Applicable.



|ITEM 16F. | CHANGE IN REGISTRANT’S CERTIFYING ACCOUNTANT
|--------- | --------------------------------------------



On December 28, 2012 Easy Health Technologies
Ltd. completed a reverse merger in which Easy Health Technologies Ltd. acquired the capital stock of Oriental Honour International
Group Limited. At the time of the reverse merger, Goldman Kurland and Mohidin, LLP was the auditor of record for Oriental Honour
International Group Limited. Accordingly, on December 28, 2012, by reason of the reverse merger, Goldman Kurland and Mohidin, LLP
became the principal independent accountant for Easy Health Technologies Ltd. Therefore, on December 28, 2012 the Board of Directors
of Easy Health Technologies Ltd. dismissed Li & Company, PC from its position as the principal independent accountant for Easy
Health Technologies Ltd.



The audit report of Li & Company, PC
on Easy Health Technologies Ltd.’s financial statements for the years ended March 31, 2012 and 2011 and the period from January
5, 2010 (inception) through March 31, 2012 contained a modification expressing substantial doubt regarding the ability of Easy
Health Technologies Ltd. to continue as a going concern. The audit report of Li & Company, PC on Easy Health Technologies Ltd.’s
financial statements for the years ended March 31, 2012 and 2011 and for the period from January 5, 2010 (inception) through March
31, 2012 did not contain any other adverse opinion or disclaimer of opinion or qualification other than the aforesaid modification.
Li & Company, PC did not, during the applicable periods, advise Easy Health Technologies Ltd. of any of the enumerated items
described in Item 16F of the Instructions to Form 20-F.



Easy Health Technologies Ltd. and Li &
Company, PC have not, during Easy Health Technologies Ltd.’s two most recent fiscal years or any subsequent period through
the date of dismissal, had any disagreement on any matter of accounting principles or practices, financial statement disclosure,
or auditing scope or procedure, which disagreement, if not resolved to Li & Company, PC’s satisfaction, would have caused
Li & Company, PC to make reference to the subject matter of the disagreement in connection with its reports.



Easy Health Technologies Ltd. has requested
Li & Company, PC to furnish a letter addressed to the Securities Exchange Commission stating whether or not Li & Company,
PC agrees with the statements in this Item 16F. A copy of the letter is filed as an exhibit to this report.



Easy Health Technologies Ltd. has retained
the firm of Goldman Kurland and Mohidin, LLP to serve as its principal independent accountant. At no time during the past two fiscal
years or any subsequent period prior to December 28, 2012 did Easy Health Technologies Ltd. consult with Goldman Kurland and Mohidin,
LLP regarding any matter of the sort described above with reference to Li & Company, PC, any issue relating to the financial
statements of Easy Health Technologies Ltd., or the type of audit opinion that might be rendered for Easy Health Technologies Ltd.



|ITEM 16G. | CORPORATE GOVERNANCE
|--------- | --------------------



Not Applicable.



|ITEM 16H. | MINE SAFETY DISCLOSURE
|--------- | ----------------------



Not Applicable.



PART III



|ITEM 17. | FINANCIAL STATEMENTS
|-------- | --------------------



Not applicable.



34







|ITEM 18. | FINANCIAL STATEMENTS
|-------- | --------------------



The consolidated financial statements and
related notes required by this item are contained on pages F-1 through F-21.



|ITEM 19. | EXHIBITS
|-------- | --------



|Exhibit
        Number |  | Description of Documents                                                                                                                                                                                                                                                
|---------------------- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|1.1                    |  | Amended and Restated Memorandum of Association                                                                                                                                                                                                                          
|1.2                    |  | Amended and Restated Articles of Association                                                                                                                                                                                                                            
|4.1                    |  | Share Exchange Agreement by and among Glorious Pioneer Investments Ltd., the shareholder of Glorious Pioneer Investments Ltd., Oriental Honour International Group Limited, and the shareholders of Oriental Honour International Group Limited  dated November 1, 2012.
|4.2                    |  | Exclusive Business Cooperation Agreement between Jinwo (Shanghai) Information Technology Co., Ltd. and Anshan Easy Health Technology Development Co., Ltd. dated July 2, 2012.                                                                                          
|4.3                    |  | Exclusive Option Agreement among Jinwo (Shanghai) Information Technology Co., Ltd., Zhang Lingxiang, Gu Song, and Anshan Easy Health Technology Development Co., Ltd. dated July 2, 2012.                                                                               
|4.4                    |  | Share Pledge Agreement among Jinwo (Shanghai) Information Technology Co., Ltd., Zhang Lingxiang, Gu Song, and Anshan Easy Health Technology Development Co., Ltd. dated July 2, 2012.                                                                                   
|4.5                    |  | Power of Attorney given by Gu Song to Jinwo (Shanghai) Information Technology Co., Ltd., dated July 2, 2012.                                                                                                                                                            
|4.6                    |  | Power of Attorney given by Zhang Lingxiang to Jinwo (Shanghai) Information Technology Co., Ltd., dated July 2, 2012.                                                                                                                                                    
|4.7                    |  | Employment Agreement dated March 9, 2012 between Anshan Easy Health Technology Development Co., Ltd. and Dong Wei.                                                                                                                                                      
|4.8                    |  | Employment Agreement dated March 9, 2012 between Anshan Easy Health Technology Development Co., Ltd. and Song Gu.                                                                                                                                                       
|4.9                    |  | Cooperation Agreement dated May 29, 2012 between Anshan Easy Health Technology Development Co., Ltd. and Fuzhou Fobes.                                                                                                                                                  
|4.10                   |  | Service Agreement dated June 20, 2012 between Anshan Easy Health Technology Development Co., Ltd. and Dayi Jingcheng (Beijing) Hospital Management Co.                                                                                                                  



|8.1 |  | Subsidiaries of the Registrant: | Oriental Honour International Group Limited, organized in Hong Kong    
|--- |  | ------------------------------- | -----------------------------------------------------------------------
|    |  |                                 | Jinwo (Shanghai) Information Technology Co., Ltd., organized in the PRC



|15.1 |  | Letter from Li and Company, PC
|---- |  | ------------------------------



35







SIGNATURES



The registrant hereby
certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned
to sign this registration statementon its behalf.







| | EASY HEALTH INVESTMENTS LTD.
| | ----------------------------
| |                             
| | By:                         
| |                             
| |                             



Date: January 16, 2013











EASY HEALTH INVESTMENTS LTD. AND SUBSIDIARIES



CONTENTS



Oriental Honour International Group Limited:



|Page   |                                                                                                                                       
|------ | --------------------------------------------------------------------------------------------------------------------------------------
|       |                                                                                                                                       
|F-2    | Report of Independent Registered Public Accounting Firm                                                                               
|       |                                                                                                                                       
|F-3    | Consolidated Balance Sheet as of July 31, 2012                                                                                        
|       |                                                                                                                                       
|F-4    | Consolidated Statement of Operations and Other Comprehensive Loss for the Period From August 1, 2011 (Inception) Through July 31, 2012
|       |                                                                                                                                       
|F-5    | Consolidated Statement of Shareholders’ Equity for the Period From August 1, 2011 (Inception) Through July 31, 2012                   
|       |                                                                                                                                       
|F-6    | Consolidated Statement of Cash Flows for the Period From August 1, 2011 (Inception) Through July 31, 2012                             
|       |                                                                                                                                       
|F-7-18 | Notes to Consolidated Financial Statements                                                                                            



Easy Health Technologies Ltd.



|Page |                                                                                                                              
|---- | -----------------------------------------------------------------------------------------------------------------------------
|     |                                                                                                                              
|F-19 | Unaudited Pro Forma Financial Statements                                                                                     
|     |                                                                                                                              
|F-20 | Unaudited Pro Forma Consolidated Balance Sheet as of July 31, 2012                                                           
|     |                                                                                                                              
|F-21 | Unaudited Pro Forma Consolidated Statement of Operations for the Period From August 1, 2011 (Inception) Through July 31, 2012



F-1







REPORT OF INDEPENDENT REGISTERED PUBLIC
ACCOUNTING FIRM



Board of Directors and Shareholders of
Oriental Honour International Group Limited



We have audited the
accompanying consolidated balance sheet of Oriental Honour International Group Limited (the “Company” or “Oriental
Honour”), its subsidiary and its variable interest entity (collectively the “Group”) as of July 31, 2012, and
the related consolidated statement of operations and comprehensive loss, stockholders’ equity, and cash flows for the period
from August 1, 2011 (inception) to July 31, 2012. These consolidated financial statements are the responsibility of the Company’s
management. Our responsibility is to express an opinion on these consolidated financial statements based on our audit.



We conducted our audit
in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we
plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material
misstatement. The Company is not required to have, nor were we engaged to perform, an audit of the Group’s internal control
over financial reporting. Our audit include consideration of internal control over financial reporting as a basis for designing
audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness
of the Group’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes
examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting
principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation.
We believe that our audit provides a reasonable basis for our opinion.



In our opinion, the
consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position
of the Group as of July 31, 2012, and the results of its operations and its cash flows for the period from August 1, 2011 (inception)
to July 31, 2012, in conformity with U.S. generally accepted accounting principles.



/s/ Goldman Kurland and Mohidin LLP



Goldman Kurland and Mohidin LLP
Encino, California
December 24, 2012



F-2







|Oriental Honour International Group Limited
|-------------------------------------------
|CONSOLIDATED BALANCE SHEET                 



|                                                                                                 |  | July 31, 2012 |          
|------------------------------------------------------------------------------------------------ |  | ------------- | ---------
|ASSETS                                                                                           |  |               |          
|Current assets                                                                                   |  |               |          
|Cash and equivalents                                                                             |  | $             | 1,701,659
|Accounts receivable                                                                              |  |               | 133,027  
|Prepaid expense                                                                                  |  |               | 6,467    
|Advance to supplier                                                                              |  |               | 6,968    
|Total current assets                                                                             |  |               | 1,848,121
|                                                                                                 |  |               |          
|Property, plant and equipment, net                                                               |  |               | 6,387    
|                                                                                                 |  |               |          
|TOTAL ASSETS                                                                                     |  | $             | 1,854,508
|                                                                                                 |  |               |          
|LIABILITIES AND STOCKHOLDERS’ EQUITY                                                             |  |               |          
|Current liabilities                                                                              |  |               |          
|Accrued expenses                                                                                 |  | $             | 2,829    
|Advance from customers                                                                           |  |               | 190,039  
|Due to shareholder                                                                               |  |               | 98,698   
|TOTAL CURRENT LIABILITIES                                                                        |  |               | 291,566  
|                                                                                                 |  |               |          
|SHAREHOLDERS’ EQUITY                                                                             |  |               |          
|Authorized capital 10,000 shares, par value $0.13 per share 10,000 shares issued and outstanding |  |               | 1,300    
|Additional paid in capital                                                                       |  |               | 1,569,875
|Accumulated other comprehensive loss                                                             |  |               | (308     
|Accumulated deficit                                                                              |  |               | (7,925   
|TOTAL SHAREHOLDERS’ EQUITY                                                                       |  |               | 1,562,942
|                                                                                                 |  |               |          
|TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY                                                       |  | $             | 1,854,508



The accompanying notes are an integral part
of these consolidated financial statements.



F-3







Oriental Honour International Group Limited

CONSOLIDATED STATEMENT OF OPERATIONS
AND OTHER COMPREHENSIVE LOSS

FROM AUGUST 1, 2011 (INCEPTION) TO JULY
31, 2012



|Operating expenses         |  |   |        |  
|-------------------------- |  | - | ------ | -
|General and administrative |  | $ | 7,817  |  
|                           |  |   |        |  
|Loss from operations       |  |   | 7,817  |  
|                           |  |   |        |  
|Other income (expenses)    |  |   |        |  
|Other expenses             |  |   | (76    | )
|                           |  |   |        |  
|Loss before income taxes   |  |   | (7,893 | )
|                           |  |   |        |  
|Income taxes               |  |   | 32     |  
|                           |  |   |        |  
|Net loss                   |  | $ | (7,925 | )
|                           |  |   |        |  
|Other comprehensive loss   |  |   | (308   | )
|                           |  |   |        |  
|Net comprehensive loss     |  | $ | (8,233 | )



The accompanying notes are an integral part
of these consolidated financial statements.



F-4







|Oriental Honour International Group Limited      
|-------------------------------------------------
|CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY   
|FROM AUGUST 1, 2011 (INCEPTION)  TO JULY 31, 2012



|                                   |  | Common stock |        |  | Share capital |   |       | Additional
    paid  in capital |  |   | Accumulated other
    comprehensive loss |  |  | Accumulated deficit |      |   | Total |  
|---------------------------------- |  | ------------ | ------ |  | ------------- | - | ----- | ------------------------------- |  | - | ---------------------------------------- |  |  | ------------------- | ---- | - | ----- | -
|Balance August 1, 2011 (inception) |  |              | -      |  |               | $ | -     |                                 |  | $ | -                                        |  |  | $                   | -    |   |       | $
|Contribution from shareholders     |  |              | 10,000 |  |               |   | 1,300 |                                 |  |   | -                                        |  |  |                     | -    |   |       |  
|Foreign currency translation       |  |              |        |  |               |   |       |                                 |  |   |                                          |  |  |                     | (308 | ) |       |  
|Net loss                           |  |              | -      |  |               |   | -     |                                 |  |   | -                                        |  |  |                     | -    |   |       |  
|VIE arrangement                    |  |              | -      |  |               |   | -     |                                 |  |   | 1,569,875                                |  |  |                     | -    |   |       |  
|Balance July 31, 2012              |  |              | 10,000 |  |               | $ | 1,300 |                                 |  | $ | 1,569,875                                |  |  | $                   | (308 | ) |       | $



The accompanying notes are an integral part
of these consolidated financial statements.



F-5







Oriental Honour International Group Limited

CONSOLIDATED STATEMENT OF CASH FLOWS

FROM AUGUST 1, 2011 (INCEPTION) TO JULY
31, 2012



|Cash flows from operating activities:                             |  |   |           |  
|----------------------------------------------------------------- |  | - | --------- | -
|Net loss                                                          |  | $ | (7,925    | )
|Adjustments to net loss to cash provided by operating activities: |  |   |           |  
|Depreciation                                                      |  |   | 141       |  
|Changes in current assets and liabilities:                        |  |   |           |  
|Accounts receivable                                               |  |   | (133,152  | )
|Prepaid expenses and other assets                                 |  |   | 925       |  
|Unearned revenue                                                  |  |   | 190,217   |  
|Accrued expenses and other current liabilities                    |  |   | 2,965     |  
|Net cash provided by operating activities                         |  |   | 53,171    |  
|                                                                  |  |   |           |  
|Cash flows from investing activities:                             |  |   |           |  
|Purchase of property and equipment                                |  |   | (435      | )
|Cash increase due to VIE arrangement                              |  |   | 1,548,990 |  
|Net cash used in investing activities                             |  |   | 1,548,555 |  
|                                                                  |  |   |           |  
|Cash flows from financing activities:                             |  |   |           |  
|Proceeds from share capital                                       |  |   | 1,285     |  
|Proceeds from borrowings from related parties                     |  |   | 98,456    |  
|Net cash provided by financing activities                         |  |   | 99,741    |  
|                                                                  |  |   |           |  
|Effect of exchange rate changes on cash & equivalents             |  |   | 192       |  
|                                                                  |  |   |           |  
|Net increase in cash and equivalents                              |  |   | 1,701,659 |  
|                                                                  |  |   |           |  
|Cash and equivalents, beginning balance                           |  |   | -         |  
|                                                                  |  |   |           |  
|Cash and equivalents, ending balance                              |  | $ | 1,701,659 |  
|                                                                  |  |   |           |  
|SUPPLEMENTARY INFORMATION:                                        |  |   |           |  
|Interest paid                                                     |  | $ | -         |  
|Income tax paid                                                   |  | $ | 32        |  



The accompanying notes are an integral part
of these financial statements.



F-6









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



NOTE 1 - ORGANIZATION AND NATURE OF BUSINESS OPERATIONS



Oriental Honour International Group Limited.
(hereinafter as "Oriental Honour " or the “Company”) was incorporated on July 28, 2011 in Hong Kong with
registered capital of $1,300 and is 100% owned by Mr. Lui Chau Pak.



Jinwo (Shanghai) Information Technology
Co., Ltd. ( hereinafter as " Jinwo ") was incorporated on May 10, 2012 in Shanghai, China with registered capital of
$100,000 and is 100% owned by Oriental Honour International Group Limited.



Anshan Easy Health Technology Development
Co., Ltd. (hereinafter as "Easy Health") was incorporated on March 9, 2012 in Anshan City, Liaoning Province, China with
registered capital of $1,583,982. Easy Health provides medical diagnostic services explained below.



Through the use of certain contractual
arrangements between Jinwo and Easy Health we are able to effectively control Easy Health’s daily operations and financial
affairs. As a result of these agreements, Jinwo is considered the primary beneficiary of Easy Health (see Note 2) and accordingly,
Easy Health’s results of operations and financial condition are consolidated in the group financial statements.



TDS Health Detection Service



The primary service offered by the Easy
Health is Tele-diagnosis System (“TDS”) health detection service. TDS uses equipment which evaluates the health condition
of a human body through detectors attached at certain points of the arms and legs.



TDS is comprised of equipment, network
and database software. TDS equipment acquires bioelectrical-current from 24 meridian points in the arms and legs of the patient
and converts it into digital signals by proprietary analog-to-digital conversion software and transmits it to the central database
via network (www.12021.cn). After comparing the data generated from the detectors connected to the patient with the standard model
pre-stored in the central database, it evaluates the health condition of the patient and generates a report. The report is transmitted
to TDS via a network (www.12021.cn).



NOTE 2 - BASIS OF PRESENTATION AND
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES



Basis of Presentation



The consolidated financial statements are
prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The
Company’s functional currency is the Chinese Renminbi (“RMB”).



F-7









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Principles of Consolidation



The accompanying consolidated
financial statements include the financial statements of the Group, which consisted of the following subsidiaries: Jinwo and
Easy Health — a variable interest entity (“VIE subsidiary”). The Company, its subsidiary and VIE
subsidiary are collectively referred to as the “Group.” The results of operations of the VIE Subsidiary are
included from July 2, 2012, the date the VIE agreement was signed.



All transactions and balances among the
Group, its subsidiary and VIE subsidiary were eliminated in consolidation.



The Company’s assets and liabilities
are mainly comprised of the assets and liabilities of the VIE. The creditors of the consolidated VIE have no recourse to the general
credit of the primary beneficiary.



Variable Interest Entity



The Company follows Accounting Standard
Codification (“ASA”) 810-10 (formerly FASB Interpretation No. 46R, “Consolidation of Variable Interest Entities,
an Interpretation of ARB No. 51,” which requires certain VIEs to be consolidated by the primary beneficiary of the entity
if the entity’s equity investors do not have the characteristics of a controlling financial interest or do not have sufficient
equity at risk for the entity to finance its activities without additional subordinated financial support from other parties.



The principal services agreements that
Jinwo entered into with Easy Health are:



On July 2, 2012, Easy Health entered into
an Exclusive Business Cooperation Agreement (“EBCA”) with Jinwo. Pursuant to the EBCA, Jinwo Shanghai will provide
Anshan business support such as management consultation, staff training, business support, financing and related services utilizing
its own human resources and capital management. The Company shall pay 100% of its net profit of each year to Jinwo for the service
provided.



On July 2, 2012, Easy Health entered into
an Exclusive Option Agreement (“EOA”) with Jinwo and the shareholders of Easy Health, Mr. Gu Song and Ms. Zhang Linxiang.
Pursuant to the EOA, the shareholders grant Jinwo an exclusive right to purchase the equity interests in Easy Health then held
by the shareholders at the best possible price. Each shareholder agrees not to exercise the first right of refusal to purchase
the equity interests to be transferred by other persons. Easy Health grants Jinwo an exclusive right to purchase the assets at
the best possible price. In consideration of the payment by Jinwo, the shareholders of Easy Health irrevocably granted Jinwo an
irrevocable and exclusive right to purchase, or designate one or more persons to purchase the equity interests in Easy Health held
by the shareholders once or at multiple times at any time.



F-8









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012





On July 2, 2012, Easy Health entered into
a Share Pledge Agreement (“SPA”) with Jinwo and the shareholders of Easy Health, Mr. Gu Song and Ms. Zhang Linxiang.
Pursuant to the SPA, the shareholders pledge to Jinwo all of the equity interests the shareholders had in Easy Health as security
for obligations and payment of the consulting and service fees by Easy Health under the EBCA.



On July 2, 2012, the shareholders of Easy
Health, Mr. Gu Song and Ms. Zhang Linxiang, entered into the Power of Attorney (“POA”) with Jinwo. Pursuant to the
POA, Jinwo was authorized to act as the shareholders’ exclusive agent with respect to all matters in Easy Health.



As a result of the agreements between Jinwo
and the shareholders of Easy Health, Jinwo is considered the primary beneficiary of Easy Health and Jinwo consolidates the results
of operations of the Easy Health and accordingly Easy Health’s results of operations, assets and liabilities are consolidated
in the Company’s financial statements from the earliest period presented. The Company’s assets and liabilities, revenue
and expenses are mainly comprised of Easy Health’s assets and liabilities, revenue and expenses.



However, the VIE is continually monitored
by the Company to determine if any events have occurred that could cause its primary beneficiary status to change. These events
include:



| | a. | The legal entity’s governing documents or contractual arrangements are changed in a manner
that changes the characteristics or adequacy of the legal entity’s equity investment at risk.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | b. | The equity investment or some part thereof is returned to the equity investors, and other interests
become exposed to expected losses of legal entity.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------



| | c. | The legal entity undertakes additional activities or acquires additional assets, beyond those that
were anticipated at the later of the inception of the entity or the latest reconsideration event, that increase the entity’s
expected losses.
| | -- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | d. | The legal entity receives an additional equity investment that is at risk, or the legal entity
curtails or modifies its activities in a way that decreases its expected losses.
| | -- | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



Based on the Company’s evaluation,
no events have occurred that resulted in change to its primary beneficiary status.



Use of Estimates



The preparation of financial statements
in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the amount of revenues
and expenses during the reporting periods. Management makes these estimates using the best information available at the time the
estimates are made. However, actual results could differ materially from those results.



F-9









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Risks and Uncertainties



The Company is subject to risks from, among
other things, competition associated with the industry in general, other risks associated with financing, liquidity requirements,
rapidly changing customer requirements, limited operating history, foreign currency exchange rates and the volatility of public
markets.



Comprehensive Income



The Company follows ASC 220 “Reporting
Comprehensive Income”, previously Statement of Financial Accounting Standards (“SFAS”) No. 130 which establishes
standards for the reporting and display of comprehensive income, its components and accumulated balances in a full set of general
purpose financial statements.



ASC 220 defines comprehensive income as
net income and all changes to the statements of shareholders' equity, except those due to investments by shareholders, changes
in paid-in capital and distributions to shareholders, including adjustments to minimum pension liabilities, accumulated foreign
currency translation, and unrealized gains or losses on marketable securities.



Foreign Currency Transactions



The Company’s accounts are maintained
in the RMB and translated into U.S. Dollars (“$ or USD”) in accordance with SFAS No. 52, "Foreign Currency Translation,"
(codified in Financial Accounting Standards (“FASB”) Accounting Standards Codification (“ASC”) Topic 810).
Under SFAS 52, all assets and liabilities are translated at the exchange rate at the date of the balance sheet; shareholders’
equity is translated at historical rates; the line items on the statement of operations are translated at the weighted average
exchange rate for the period. The resulting translation adjustments are reported under other comprehensive income in accordance
with SFAS No. 130, “Reporting Comprehensive Income”. Gains and losses resulting from the translations of foreign currency
transactions and balances are reflected in the operations statement.



Translations adjustments resulting from
this process included in accumulated other comprehensive loss in stockholders’ equity were$308
as of July 31, 2012.



Cash and Equivalents



For Statement of Cash Flows purposes, the
Company considers all cash on hand and in banks, including accounts in book overdraft positions, certificates of deposit and other
highly-liquid investments with maturities of three months or less, when purchased, to be cash and equivalents. The Company maintains
cash with various banks and trust companies located in China. Cash accounts are not insured or otherwise protected. Should any
bank or trust company holding cash deposits become insolvent, or if the Company is otherwise unable to withdraw funds, the Company
would lose the cash on deposit with that particular bank or trust company.



F-10









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Accounts Receivable



The Company maintains reserves for potential
credit losses on accounts receivable. Management reviews the composition of accounts receivable and analyzes historical bad debts,
customer concentrations, customer credit worthiness, current economic trends and changes in customer payment patterns to evaluate
the adequacy of these reserves. Accounts are written off against the allowance when it becomes evident collection will not occur.
Our standard terms for accounts receivable from our customers are 90 days from close of the billing cycle. As of July 31, 2012,
management concluded there are no past due accounts receivable and no bad debt allowance were recorded.



The Company collected its outstanding accounts
receivable in August 2012.



Property, Plant and Equipment



Property, plant and equipment are recorded
at cost. Gains or losses on disposals are reflected as gain or loss in the year of disposal. Expenditures for maintenance and repairs
are expensed as incurred. Major renewals and betterments are charged to the property accounts while replacements, maintenance and
repairs, which do not improve or extend the lives of the respective assets, are expensed in the current period.



Depreciation for financial reporting purposes
is provided using the straight-line method over the estimated useful lives of assets as set out below.



|Fixed Asset Class    |  | Estimated Useful Lives
|-------------------- |  | ----------------------
|Office furniture     |  | 5 years               
|Electronic equipment |  | 3 years               



Impairment of Long-lived Assets



In accordance with ASC 360, “Property,
Plant and Equipment”, previously SFAS No. 144, the Company reviews the carrying values of long-lived assets, including property,
plant and equipment and other intangible assets, whenever facts and circumstances indicate the assets may be impaired. Recoverability
of assets to be held and used is measured by comparing the carrying amount of an asset to future net undiscounted cash flows expected
to be generated by the asset. If an asset is considered impaired, the impairment is measured by the amount by which the carrying
amount of the asset exceeds its fair value (“FV”). Assets to be disposed of are reported at the lower of the carrying
amount or FV, less costs of disposal. There was no significant impairment of long lived assets during the period from inception
to July 31, 2012.



F-11









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Revenue Recognition



The Company sells membership cards to agents
which sell them to the patients. TDS diagnosis service is provided by the agent to the patients. The Company provides TDS equipment
to agents for free.



Each patient may use TDS diagnosis service
twice a year. The Company recognizes revenue when a patient activates the card via network (www.12021.cn). The TDS diagnosis
can be performed at the agent’s office or by the mobile service offered by the agent at the patient’s home. When the
Company collects proceeds from an sale of membership cards from agent, it records these proceeds as unearned revenue.



Income Taxes



The Company accounts for income taxes in
accordance with ASC 740 “Income Taxes”, previously SFAS No. 109. Under this method, deferred income taxes are recognized
for the estimated tax consequences in future years of differences between the tax bases of assets and liabilities and their financial
reporting amounts and each year-end based on enacted tax laws and statutory rates applicable to the periods in which the differences
are expected to affect taxable income. Valuation allowances are established to reduce deferred tax assets to the amount expected
to be realized when, in management’s opinion; it is more likely than not that some portion of the deferred tax assets will
not be realized. The provision for income taxes represents current taxes payable net of the change during the period in deferred
tax assets and liabilities.



Fair Values of Financial Instruments



ASC 820 “Fair Value Measurements
and Disclosures”, previously SFAS 157, adopted January 1, 2008, defines FV, establishes a three-level valuation hierarchy
for disclosures of FV measurement and enhances disclosure requirements for FV measures. The carrying amounts reported in the balance
sheets for current receivables and payables qualify as financial instruments. Management concluded the carrying values are a reasonable
estimate of FV because of the short period of time between the origination of such instruments and their expected realization and
if applicable, their stated interest rate approximates current rates available. The three levels are defined as follows:



·  Level 1 inputs
to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.



·  Level 2 inputs
to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable
for the assets or liability, either directly or indirectly, for substantially the full term of the financial instruments.



·  Level 3 inputs
to the valuation methodology are unobservable and significant to the FV.



F-12









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012





Fair Values of Financial Instruments
(continued)



The assets measured
at FV on a recurring basis subject to the disclosure requirements of ASC 820 as ofJuly 31, 2012
is as follows:



|                     |  | Carrying Value |           |  | Active  markets For  Identical Assets |   |           | Significant Other Observable Inputs |  |  | Significant Unobservable Inputs | 
|-------------------- |  | -------------- | --------- |  | ------------------------------------- | - | --------- | ----------------------------------- |  |  | ------------------------------- | 
|                     |  |                |           |  | (Level 1)                             |   |           | (Level 2)                           |  |  | (Level 3)                       | 
|                     |  |                |           |  |                                       |   |           |                                     |  |  |                                 | 
|Cash and equivalents |  | $              | 1,701,659 |  |                                       | $ | 1,701,659 |                                     |  |  | -                               | 



The Company's financial instruments include
cash and equivalents. Cash and equivalents consist primarily of high rated money market funds at a variety of well-known institutions
with original maturities of three months or less. Management estimates the carrying amounts of the non-related party financial
instruments approximate their FV due to their short-term nature.



Concentration of Credit Risk



Financial instruments that potentially
subject the Company to significant concentrations of credit risk consist principally of cash and equivalents and accounts receivables.
As of July 31, 2012, substantially all of the Company’s cash and equivalents were held by major financial institutions located
in the PRC, which management believes are of high credit quality. With respect to accounts receivables, the Company extends credit
based on an evaluation of the customer’s financial condition. The Company generally does not require collateral for accounts
receivables and maintains an allowance for doubtful accounts of accounts receivables.



The Company currently sells its membership
cards to two agents. The Company has a signed agency agreement with each of the agents. They purchase membership cards from the
Company and sell those cards to patients. As of July 31, 2012, Company sold 1,000 cards to each of the agents which is the only
source of the Company’s revenue.



Statement of Cash Flows



In accordance with ASC 230, “Statement
of Cash Flows”, previously SFAS No. 95, cash flows from the Company's operations are calculated based upon the local currencies.
As a result, amounts related to assets and liabilities reported on the statement of cash flows may not
necessarily agree with changes in the corresponding balances on the balance sheet.



F-13









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Recent Accounting Pronouncements



In July 2012, the FASB issued ASU 2012-02,
Intangibles-Goodwill and Other (Topic 350) - Testing Indefinite-Lived Intangible Assets for Impairment.  The ASU provides
entities with an option to first assess qualitative factors to determine whether events or circumstances indicate it is more likely
than not that the indefinite-lived intangible asset is impaired.  If an entity concludes it is more than 50% likely that an
indefinite-lived intangible asset is not impaired, no further analysis is required.  However, if an entity concludes otherwise,
it would be required to determine the FV of the indefinite-lived intangible asset to measure the amount of impairment, if any,
as currently required under US GAAP. The ASU is effective for annual and interim impairment tests performed for fiscal years beginning
after September 15, 2012.  Early adoption is permitted.The adoption of this pronouncement will
not have a material impact on our financial statements.



As of July 31, 2012, there are no other
recently issued accounting standards not yet adopted that would have a material effect on the Company’s financial statements.



NOTE 3 - ADVANCE TO SUPPLIER



As of July 31, 2012, the Company’s
advance to supplier consisted of the following:



|Fuzhou Fobes Medical Devices Development Co., Ltd (“Fobes”). |  | $ | 6,968 | 
|------------------------------------------------------------ |  | - | ----- | 



The Company purchases TDS equipment from
Fobes. For each diagnosis completed through TDS equipment, Company pays $6 (RMB 40) to Fobes and Fobes in turn pays $5 (RMB 30)
to the agent which performs TDS diagnosis. Fobes keeps $1 as part of this for equipment maintenance, training and consulting fees.



NOTE 4 - PREPAID EXPENSE



As of July 31, 2012, the Company’s
prepaid expense was for office rent.



NOTE 5 - PROPERTY, PLANT AND EQUIPMENT



As of July 31, 2012, the Company’s
property, plant and equipment consisted of the following:



|Electronic equipment               |  | $ | 4,592 |  
|---------------------------------- |  | - | ----- | -
|Office equipment                   |  |   | 2,217 |  
|Total                              |  |   | 6,809 |  
|Less: Accumulated depreciation     |  |   | (422  | )
|Property, plant and equipment, net |  | $ | 6,387 |  



Depreciation for the period from inception
to July 31, 2012 was $141.



F-14









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



NOTE 6 – DUE TO SHAREHOLDER



The Company borrowed funds to invest in
Jinwo from a shareholder of Oriental Honour-“Mr. Lui Chau Pak”. This loan is interest free and due on demand.



NOTE 7 – SHARE CAPITAL



The Company has registered capital of HKD
10,000 ($1,300) consisted of 10,000 shares of HK$1.00 ($0.13) each.



NOTE 8 - UNEARNED REVENUE



As of July 31,
2012, the Company’s unearned revenueconsisted of the following:



|Anshan Lu Men Trading Co., Ltd.               |  | $ | 95,019  | 
|--------------------------------------------- |  | - | ------- | 
|Anshan Lan Yang Property Management Co., Ltd. |  |   | 95,020  | 
|Total                                         |  | $ | 190,039 | 



On June 23, 2012, the Company signed agency
contract with two agents. According to the contract terms, as of July 31, 2012, the Company sold 2,000 membership cards to two
agents for $190,039 and recorded it as unearned revenue.



The Company sells membership cards for
$95 (RMB 600) per card to its agents. The agent sells the membership card to each patient for $125 (RMB 800) per card.



As of July 31, 2012, each agent is committed to sell membership
cards as follows by calendar year:



|2012                           |  | $ | 160,000   | 
|------------------------------ |  | - | --------- | 
|2013                           |  | $ | 315,000   | 
|2014                           |  | $ | 475,000   | 
|2015                           |  | $ | 475,000   | 
|2016                           |  | $ | 475,000   | 
|Total minimum sales commitment |  | $ | 1,900,000 | 



Starting from 2013, the Company is entitled
to cancel an agency contract, if the agent’s sales for two consecutive quarters are less than $50,000.



The agency contracts expire on December
31, 2016.



F-15









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012





NOTE 9 - INCOME TAX



The Company is governed by the Income Tax
Law of Hong Kong (“HK”) concerning private-run enterprises, which are generally subject to tax at 16.5% on income reported
in the statutory financial statements after appropriate tax adjustments.



Jinwo and its VIE, Anshan Easy Health,
are governed by the Income Tax Law of the PRC concerning private-run enterprises, which are generally subject to tax at 25% on
income reported in the statutory financial statements after appropriate tax adjustments.



The Company paid minimum tax of $32 and
had pre-tax loss of $7,893 for the period from inception to July 31, 2012. The following table reconciles the HK statutory rates
to the Company’s effective tax rate for the period ended July 31, 2012:



|HK statutory tax rate        |  |  | 16.5  | % 
|---------------------------- |  |  | ----- | --
|PRC tax rate difference      |  |  | 8.5   | % 
|Loss for the period          |  |  | (25.4 | )%
|Tax per financial statements |  |  | (0.4  | )%



NOTE 10 - STATUTORY RESERVES



As stipulated by the Company Law of the
PRC, net income after taxation can only be distributed as dividends after appropriation has been made for the following:



i) Making up cumulative prior years' losses,
if any;



ii) Allocations to the "Statutory
surplus reserve" of at least 10% of income after tax, as determined under PRC accounting rules and regulations, until the
fund amounts to 50% of the Company's registered capital;



iii) Allocations of 5-10% of income after
tax, as determined under PRC accounting rules and regulations, to the Company's "Statutory common welfare fund," which
is established for the purpose of providing employee facilities and other collective benefits to the Company's employees; and Statutory
common welfare fund is no longer required per the new cooperation law executed in 2006.



iv) Allocations to the discretionary surplus
reserve, if approved in the shareholders' general meeting.

The Company did not any appropriate statutory reserve for the period from inception to July 31, 2012.



F-16









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



NOTE 11 - OPERATING RISK



Industry risk



The industry in which we compete is a rapidly
evolving, highly competitive and fragmented market driven by consumer preferences and quickly evolving technology. Increased competition
may result in price reductions, reduced gross margin and loss of market share. Failure to compete successfully against current
or future competitors could have a material adverse effect on the Company’s business, operating results and financial condition.



Exchange risk



The Company cannot guarantee the Renminbi
and USD exchange rate will remain steady; therefore, the Company could post the same profit for two comparable periods and post
higher or lower profit depending on exchange rate of Renminbi and USD. The exchange rate could fluctuate depending on changes in
the political and economic environments without notice.



Political risk



Currently, the PRC is in a period of growth
and is promoting business development to bring more business into PRC. Additionally the PRC currently allows a Chinese corporation
to be owned by a US corporation. If the laws or regulations relating to ownership of a Chinese corporation are changed by the PRC
government, the Company's ability to operate the PRC subsidiaries could be affected.



NOTE 12 - CommitmentS



Purchase commitment



On May 29, 2012, the Company signed a Cooperation
Agreement with Fobes, a third party, to purchase TDS detector equipment from May 29, 2012 to May 28, 2017.



The future minimum annual purchase commitment
as of July 31, 2012, by calendar year, is as follows:



|2012                              |  | $ | 72,000  | 
|--------------------------------- |  | - | ------- | 
|2013                              |  |   | 159,000 | 
|2014                              |  |   | 238,000 | 
|2015                              |  |   | 238,000 | 
|2016                              |  |   | 238,000 | 
|Total minimum purchase commitment |  | $ | 945,000 | 



F-17









ORIENTAL HONOUR INTERNATIONAL GROUP LIMITED



NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

JULY 31, 2012



Operating lease commitment



The
Company signed a long-term lease in March 2012, to rent office from a non-related party for annual rent of $11,097 from March 2012
to March 2015.



The future minimum annual rental commitments
as of July 31, 2012 are as follows:



|2013  |  | $ | 11,000 | 
|----- |  | - | ------ | 
|2014  |  |   | 11,000 | 
|2015  |  |   | 7,000  | 
|Total |  | $ | 29,000 | 



NOTE 13 – SUBSEQUENT EVENT



On August 31, 2012, Oriental Honour and
its sole shareholder entered into a share exchange agreement. Pursuant to the share exchange agreement, Mr. Lui Chau Pak (the former
shareholder) transferred 4,172 of 10,000 shares to Mark Time Development Limited in the consideration of HKD 4,172, transferred
1,448 of 10,000 shares to Mascot Fortune International Limited in the consideration of HKD 1,448, transferred 1,000 of 10,000 shares
to Industrial Express Limited in the consideration of HKD 1,000, transferred 410 of 10,000 shares to
Kin Wang Lui in the consideration of HKD 410, transferred 400 of 10,000 shares to City Linkage Holdings Limited in the consideration
of HKD 400, transferred 400 of 10,000 shares to Sui Hung Cheng in the consideration of HKD 400, transferred 400 of 10,000 shares
to Shueng Lam Lui in the consideration of HKD 400, transferred 340 of 10,000 shares to Songlin Su in the consideration of HKD 340,
transferred 340 of 10,000 shares to Guangxing Gao in the consideration of HKD 340, transferred 300 of 10,000 shares to Limin Yuan
in the consideration of HKD 300 and transferred 300 of 10,000 shares to Shaoping Cheng in the consideration of HKD 300. After the
share exchange, Mr. Lui Chau Pakremained 490 of 10,000 shares of HKD 490. The share exchange was completed on
September 14, 2012.



On
November 1, 2012, Easy Health Technologies Ltd (formerly known as Glorious Pioneer Investments Ltd) and its sole shareholder entered
into a share exchange agreement with Oriental Honour and the shareholders of Oriental Honour. Pursuant to the share exchange agreement,
on December 28, 2012, Easy Health acquired from the shareholders of Oriental Honour all of the issued and outstanding shares of
Oriental Honour, in exchange for 15,000,000 newly issued ordinary shares issued by Easy Health to the shareholders of Oriental
Honour. In addition, the sole shareholder of Easy Health sold all of the 5,000,000 ordinary shares of Easy Health that were issued
and outstanding prior to the reverse acquisition, to the shareholders of Oriental Honour for $450,000 (which is equal to $0.09
per share) in cash. As a result, the individuals and entities that owned shares of Oriental Honour prior to the reverse acquisition
acquired 100% of the equity of Easy Health, and Easy Health acquired 100% of the equity of Oriental Honour. Oriental Honour is
now a wholly owned subsidiary of Easy Health. In anticipation of the reverse acquisition, Easy Health filed an amended charter,
pursuant to which Easy Health changed its fiscal year end to July 31, changed the par value of its ordinary shares to $0.01 per
share and increased its authorized shares to 100,000,000.









F-18









EASY HEALTH TECHNOLOGY LTD.



Pro Forma Financial Statements



The following pro forma unaudited
consolidated financial statements as of July 31, 2012 and for the period from August 1, 2011 (inception) to July 31, 2012 are
presented below, assuming an acquisition occurred on August 1, 2011. These pro forma financial statements were prepared for
that purpose only and do not purport to be indicative of what operating results would have been and may not be indicative of
future operating result.



F-19







|UNAUDITED PRO FORMA CONSOLIDATED
|--------------------------------
|BALANCE SHEET                   
|AS OF JULY 31, 2012             



|                                                                                                             |  | Oriental Honour
    (Consolidated) |           |   | Easy Health |   |          | Combined |  |   | Elimination |   |  | Consolidated |       
|------------------------------------------------------------------------------------------------------------ |  | ---------------------------------- | --------- | - | ----------- | - | -------- | -------- |  | - | ----------- | - |  | ------------ | ------
|ASSETS                                                                                                       |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Current assets                                                                                               |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Cash and equivalents                                                                                         |  | $                                  | 1,701,659 |   |             | $ | -        |          |  | $ | 1,701,659   |   |  |              |       
|Accounts receivable                                                                                          |  |                                    | 133,027   |   |             |   | -        |          |  |   | 133,027     |   |  |              |       
|Other receivable                                                                                             |  |                                    | -         |   |             |   | 2,500    |          |  |   | 2,500       |   |  |              |       
|Prepaid expenses                                                                                             |  |                                    | 6,467     |   |             |   | -        |          |  |   | 6,467       |   |  |              |       
|Advance to suppliers                                                                                         |  |                                    | 6,968     |   |             |   | -        |          |  |   | 6,968       |   |  |              |       
|Total current assets                                                                                         |  |                                    | 1,848,121 |   |             |   | 2,500    |          |  |   | 1,850,621   |   |  |              | -     
|                                                                                                             |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Property, plant and equipment, net                                                                           |  |                                    | 6,386     |   |             |   | -        |          |  |   | 6,386       |   |  |              |       
|                                                                                                             |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|TOTAL ASSETS                                                                                                 |  | $                                  | 1,854,508 |   |             | $ | 2,500    |          |  | $ | 1,857,008   |   |  |              | -     
|                                                                                                             |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|LIABILITIES AND STOCKHOLDERS’ EQUITY                                                                         |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Current liabilities                                                                                          |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Accrued expenses and other payables                                                                          |  | $                                  | 2,829     |   |             | $ | 2,063    |          |  | $ | 4,892       |   |  |              |       
|Advance from customers                                                                                       |  |                                    | 190,039   |   |             |   | -        |          |  |   | 190,039     |   |  |              |       
|Due to shareholder                                                                                           |  |                                    | 98,698    |   |             |   | -        |          |  |   | 98,698      |   |  |              |       
|TOTAL CURRENT LIABILITIES                                                                                    |  |                                    | 291,565   |   |             |   | 2,063    |          |  |   | 293,628     |   |  |              | -     
|                                                                                                             |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|SHAREHOLDERS’ EQUITY                                                                                         |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|Common stock at $0.01 par value: 100,000,000 shares authorized, and 20,000,000 shares issued and outstanding |  |                                    |           |   |             |   | 200,000  |          |  |   | 200,000     |   |  |              |       
|Authorized capital 10,000 shares, par value $0.13 per share 10,000 shares issued and outstanding             |  |                                    | 1,300     |   |             |   |          |          |  |   | 1,300       |   |  |              | (1,300
|Additional Paid-in capital                                                                                   |  |                                    | 1,583,968 |   |             |   | (199,563 | )        |  |   | 1,384,405   |   |  |              | 1,300 
|Accumulated other comprehensive loss                                                                         |  |                                    | (308      | ) |             |   |          |          |  |   | (308        | ) |  |              |       
|Accumulated deficit                                                                                          |  |                                    | (22,018   | ) |             |   |          |          |  |   | (22,018     | ) |  |              |       
|TOTAL SHAREHOLDERS’ EQUITY                                                                                   |  |                                    | 1,562,942 |   |             |   | 437      |          |  |   | 1,563,379   |   |  |              | -     
|                                                                                                             |  |                                    |           |   |             |   |          |          |  |   |             |   |  |              |       
|TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY                                                                   |  | $                                  | 1,854,508 |   |             | $ | 2,500    |          |  | $ | 1,857,008   |   |  |              | -     



F-20







|UNAUDITED PRO FORMA CONSOLIDATED                 
|-------------------------------------------------
|STATEMENT OF OPERATIONS                          
|FROM AUGUST 1, 2011 (INCEPTION)  TO JULY 31, 2012





|                                                       |  | Oriental Honour (Consolidated) |        |   | Easy Health |   |            | Combined |  |   | Elimination |   |  | Consolidated |  
|------------------------------------------------------ |  | ------------------------------ | ------ | - | ----------- | - | ---------- | -------- |  | - | ----------- | - |  | ------------ | -
|Operating expenses                                     |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Sales and marketing                                    |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|General and administrative                             |  | $                              | 7,817  |   |             | $ |            |          |  | $ | 7,817       |   |  |              |  
|Loss from operations                                   |  |                                | 7,817  |   |             |   | -          |          |  |   | 7,817       |   |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Other income (expenses)                                |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Other expenses                                         |  |                                | (76    | ) |             |   |            |          |  |   | (76         | ) |  |              |  
|Total other income                                     |  |                                | (76    | ) |             |   | -          |          |  |   | (76         | ) |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Loss before income taxes                               |  |                                | (7,893 | ) |             |   | -          |          |  |   | (7,893      | ) |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Income taxes                                           |  |                                | 32     |   |             |   |            |          |  |   | 32          |   |  |              |  
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Net loss                                               |  | $                              | (7,925 | ) |             | $ | -          |          |  | $ | (7,925      | ) |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Other comprehensive gain                               |  |                                | (308   | ) |             |   |            |          |  |   | (308        | ) |  |              |  
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Net comprehensive loss                                 |  | $                              | (8,233 | ) |             | $ | -          |          |  | $ | (8,233      | ) |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Weighted common shares outstanding - basic and diluted |  |                                | -      |   |             |   | 20,000,000 |          |  |   | 20,000,000  |   |  |              | -
|                                                       |  |                                |        |   |             |   |            |          |  |   |             |   |  |              |  
|Net loss per common share - basic and diluted          |  | $                              | -      |   |             | $ | -          |          |  | $ | (0.00       | ) |  |              | -





F-21